Benign neoplasm of other and ill-defined parts of digestive system

CD2_BENIGN_OTHERDIGESTIVE_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions None
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D13 Cause of death: ICD-10 — D13 2 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints CD2_BENIGN_OESOPHAGUS CD2_BENIGN_STOMACH CD2_BENIGN_SMALL_INTESTINE CD2_BENIGN_LIVE_BILE CD2_BENIGN_PANCREAS CD2_BENIGN_ENDOCRINE_PANCREAS CD2_BENIGN_DIGESTIVE_NOS	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D10-D36
Name in latin: Neoplasmata benigna aliarum sive male specificatarum partium organorum digestoriorum

NAME	CD2_BENIGN_OTHERDIGESTIVE_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	CD2_BENIGN_OESOPHAGUS\|CD2_BENIGN_STOMACH\|CD2_BENIGN_SMALL_INTESTINE\|CD2_BENIGN_LIVE_BILE\|CD2_BENIGN_PANCREAS\|CD2_BENIGN_ENDOCRINE_PANCREAS\|CD2_BENIGN_DIGESTIVE_NOS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D13
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D13
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm of other and ill-defined parts of digestive system based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	7203	4463	2740
Unadjusted period prevalence (%)	1.40	1.52	1.21
Median age at first event (years)	63.27	61.18	66.68

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
6419: Matched controls
64190

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

D13.0

ICD-10 Finland

Benign neoplasm: Oesophagus

988.0

323.0

373

130

Kela drug reimbursment

Malignant tumour

+∞

323.0

522

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

10.6

323.0

4533

11899

UJF32

NOMESCO Finland

Coloscopy

3.6

323.0

2620

10239

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

4196.5

323.0

765

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

1556.2

323.0

3260

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

200.5

323.0

342

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

28.4

323.0

680

266

115

Kela drug reimbursment

Breast cancer

+∞

323.0

315

D13.6

ICD-10 Finland

Benign neoplasm: Pancreas

2088.7

323.0

707

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

323.0

341

C61

ICD-10 Finland

Malignant neoplasm of prostate

274.9

323.0

363

D13.4

ICD-10 Finland

Benign neoplasm: Liver

1484.0

323.0

666

D13.3

ICD-10 Finland

Benign neoplasm: Other and unspecified parts of small intestine

5060.5

323.0

480

H02AB02

ATC

dexamethasone; systemic

20.9

318.0

484

250

A03FA01

ATC

metoclopramide; systemic, rectal

4.1

314.2

1441

4269

JN4BD

NOMESCO Finland

Extensive body CT

6.9

302.8

817

1333

A02BC02

ATC

pantoprazole; systemic

2.7

283.6

4728

32467

PJA12

NOMESCO Finland

Sentinel node biopsy

299.7

281.6

285

A04AA02

ATC

granisetron; systemic, transdermal

145.6

275.1

292

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

263.3

251

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.6

255.7

2743

14387

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

78.6

245.0

278

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

153.5

237.5

251

A02BC05

ATC

esomeprazole; systemic

2.4

230.2

3183

18757

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

2128.8

224.0

216

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

12.3

222.9

419

363

WX302

NOMESCO Finland

Thoracal epidural anesthesy

9.6

222.8

476

529

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

4.1

222.7

983

2735

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

17.5

221.1

357

215

XJD02

NOMESCO Finland

Peroral endoscopic ultrasonography

34.9

214.2

281

JN3BD

NOMESCO Finland

Extensive abdominal CT

3.6

201.1

1011

3127

116

Kela drug reimbursment

Prostate cancer

+∞

200.0

191

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

4.1

199.7

862

2334

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

1822.3

193.6

187

D37.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Stomach

47.9

192.4

236

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

190.5

182

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

249.9

189.7

194

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

3.3

184.4

1083

3758

D37.6

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Liver, gallbladder and bile ducts

20.9

184.4

279

139

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.4

179.3

1988

10128

D13.7

ICD-10 Finland

Benign neoplasm: Endocrine pancreas

1853.3

177.8

172

L01BC06

ATC

capecitabine; oral

+∞

175.8

168

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.1

171.7

1075

3887

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

13.0

169.2

308

247

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

168.0

3015

19022

JN4AD

NOMESCO Finland

Body CT examination

6.0

164.9

488

875

WF002

NOMESCO Finland

Radical radiotherapy

47.9

163.1

200

D13.9

ICD-10 Finland

Benign neoplasm: Ill-defined sites within the digestive system

1661.4

162.1

157

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.6

161.2

1387

6106

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

1623.7

158.9

154

L03AA13

ATC

pegfilgrastim; parenteral

534.1

158.5

157

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

3.8

157.7

747

2171

B01AB05

ATC

enoxaparin; parenteral

2.2

155.5

2102

11608

WX408

NOMESCO Finland

General anesthesy, balanced

2.3

151.8

1783

9200

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.4

149.3

1541

7445

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

3.1

148.3

935

3369

HAC20

NOMESCO Finland

Total mastectomy

146.2

147.9

157

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

1462.3

145.3

141

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

140.9

1504

7359

L02BG04

ATC

letrozole; oral

18.2

138.8

220

125

ZX120

NOMESCO Finland

Intravenous

3.6

138.0

688

2075

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

4.2

137.1

562

1428

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.4

137.0

1379

6534

A09AA02

ATC

multienzymes (lipase, protease etc.)

10.7

135.8

272

265

A02BC03

ATC

lansoprazole; oral

2.0

134.9

2250

13403

A04AA01

ATC

ondansetron; systemic, rectal

6.7

134.6

362

570

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.8

134.3

1003

4014

L02BA01

ATC

tamoxifen; oral

106.7

133.6

146

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

8.4

132.1

304

379

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

131.7

126

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

6.0

130.6

383

675

D64.9

ICD-10 Finland

Anaemia, unspecified

3.0

130.4

864

3201

ZX090

NOMESCO Finland

Other technic of radiotherapy

331.1

130.0

131

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

128.5

123

N02BE01

ATC

paracetamol; systemic, rectal

2.3

127.8

5568

47403

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

127.1

2397

14894

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

16.5

126.7

208

130

JLC30

NOMESCO Finland

Pancreatoduodenectomy

217.5

124.2

128

WX402

NOMESCO Finland

General anaesthesia

2.6

123.4

1029

4377

XX3DW

NOMESCO Finland

Time consuming IT work

4.1

122.2

512

1324

JN4CD

NOMESCO Finland

Very extensive body CT

8.4

121.5

279

346

ZXD10

NOMESCO Finland

Scheduled procedure

1.9

121.1

2582

16706

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

120.1

1600

8584

UJF30

NOMESCO Finland

Ileoscopy through colon

2.9

119.3

812

3047

A02BC01

ATC

omeprazole; systemic

2.0

119.0

2040

12140

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

84.3

117.6

132

R4110

NOMESCO Finland

Physiotherapy

2.1

116.8

1781

10097

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

176.1

115.7

121

L03AA02

ATC

filgrastim; parenteral

65.1

115.2

134

K29.4

ICD-10 Finland

Chronic atrophic gastritis

6.1

115.0

329

561

HAB40

NOMESCO Finland

Wedge excision of mammary gland

17.3

114.8

185

110

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

9.4

114.2

245

271

TPH07

NOMESCO Finland

Cathetrisation of artery

2.9

113.7

754

2779

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

567.8

113.3

112

JJ1CE

NOMESCO Finland

Liver, bile duct and pancreas endoscopic ultrasound examination

45.7

112.6

139

Z2221

NOMESCO Finland

Medical doctor

2.0

112.3

1888

11095

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

562.6

112.2

111

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

111.8

107

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.9

111.0

2205

13784

N02AX02

ATC

tramadol; systemic, rectal

1.8

109.9

2799

19063

UJD02

NOMESCO Finland

Gastroscopy

3.7

108.9

510

1450

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

108.6

104

WF049

NOMESCO Finland

Radiotherapy of metastasis

536.6

107.0

106

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.3

106.5

418

1013

WX002

NOMESCO Finland

Sedation and analgesia

2.1

106.0

1455

7843

Z51.5

ICD-10 Finland

Palliative care

6.3

103.8

289

475

N02AA05

ATC

oxycodone; systemic

2.6

103.3

878

3746

A06AC01

ATC

ispaghula (psylla seeds); oral

2.0

102.8

1812

10768

ZXE20

NOMESCO Finland

More than three and less than five hours

2.4

101.1

937

4185

B03BA03

ATC

hydroxocobalamin; parenteral

3.3

99.8

541

1724

JN3AD

NOMESCO Finland

Abdominal CT examination

3.1

99.7

588

1992

A04AA55

ATC

palonosetron, combinations; systemic

962.6

97.2

WF003

NOMESCO Finland

Adjuvant radiotherapy

116.3

95.2

103

C50.99

ICD-10 Finland

Breast, unspecified

474.6

94.6

B01AB10

ATC

tinzaparin; parenteral

3.8

94.4

430

1191

Z3231

NOMESCO Finland

Registered nurse

1.9

93.3

1764

10685

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

921.4

93.1

K30

ICD-10 Finland

Functional dyspepsia

2.5

93.0

842

3702

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

3.5

92.7

468

1410

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

71.6

92.6

106

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.6

92.3

444

1286

HA1AA

NOMESCO Finland

X-ray mammography

4.5

92.0

347

807

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

3.4

91.3

486

1525

Z3226

NOMESCO Finland

Physiotherapist

2.1

91.2

1273

6851

J01MA02

ATC

ciprofloxacin; systemic

1.8

89.8

2472

16906

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

30.0

89.4

121

D13.5

ICD-10 Finland

Benign neoplasm: Extrahepatic bile ducts

+∞

88.7

107

Kela drug reimbursment

Pernicious anaemia

6.1

87.0

247

416

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.9

87.0

298

627

WW500

NOMESCO Finland

Blood transfusion

5.9

86.0

251

438

UJF92

NOMESCO Finland

Capsular endoscopy

6.0

85.7

248

428

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

66.2

84.7

L02AE02

ATC

leuprorelin; implant, parenteral

12.2

83.8

156

131

J01DB01

ATC

cefalexin; oral

1.8

82.5

5023

42854

A02BA02

ATC

ranitidine; systemic

1.9

81.6

1441

8444

A04AD12

ATC

aprepitant; systemic

212.6

81.5

K86.2

ICD-10 Finland

Cyst of pancreas

10.9

80.5

158

148

JLC10

NOMESCO Finland

Distal pancreatectomy

76.1

79.3

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

78.3

R4190

NOMESCO Finland

Nutritional therapy

5.2

76.9

250

496

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.6

76.3

594

2389

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

76.2

NK6AN

NOMESCO Finland

Total body bone isotope imaging

24.5

74.2

106

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.9

72.6

1284

7481

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

18.5

72.3

113

J01MA12

ATC

levofloxacin; systemic

2.0

72.3

1149

6435

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

72.0

WZC30

NOMESCO Finland

Teaching

2.4

71.4

684

3070

R06.0

ICD-10 Finland

Dyspnoea

1.8

71.1

1673

10716

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

70.9

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

70.9

ZXE00

NOMESCO Finland

One hour or less

1.6

70.0

2378

16923

K92.1

ICD-10 Finland

Melaena

3.1

69.9

410

1373

N03AX16

ATC

pregabalin; oral

1.8

69.6

1539

9653

JAH01

NOMESCO Finland

Laparoscopy

3.7

69.5

325

917

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

5.9

69.5

201

347

R07.4

ICD-10 Finland

Chest pain, unspecified

1.7

69.1

1847

12274

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.6

69.0

568

2350

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

68.9

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

68.9

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

145.5

68.0

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

67.8

L02BB03

ATC

bicalutamide; oral

+∞

67.8

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.0

67.6

1052

5831

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.4

67.4

650

2924

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

4.0

67.2

288

754

Y77

ICPC

Malignant neoplasm prostate

121.3

67.0

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

16.0

66.7

110

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

10.6

66.5

132

127

JAH00

NOMESCO Finland

Laparotomy

5.0

66.1

222

457

C16.9

ICD-10 Finland

Malignant neoplasm: Stomach, unspecified

+∞

65.7

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

4.0

65.7

278

719

R50.9

ICD-10 Finland

Fever, unspecified

2.1

65.5

790

3943

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

7.1

65.2

165

238

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

644.5

65.0

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

26.8

64.8

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

64.7

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

63.6

WX110

NOMESCO Finland

Local anesthesy

1.6

63.4

3951

32427

B81

ICPC

Anaemia vit B12/folate deficiency

3.3

63.2

343

1087

JDA63

NOMESCO Finland

Local excision of lesion of stomach

99.6

62.9

H02AB06

ATC

prednisolone; systemic

1.6

62.3

2886

22021

JDH05

NOMESCO Finland

Endoscopic polypectomy in duodenum

215.3

62.2

C50

ICD-10 Finland

Malignant neoplasm of breast

211.9

61.2

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

603.6

60.8

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

603.6

60.8

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

60.5

R13

ICD-10 Finland

Dysphagia

2.5

59.6

492

2036

A02BC04

ATC

rabeprazole; oral

2.3

59.2

621

2900

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

107.7

58.9

XKD00

NOMESCO Finland

Uroflowmetry

2.0

58.4

847

4547

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

4.3

58.3

228

548

J02AC01

ATC

fluconazole; systemic

1.6

58.3

2402

17717

S18

ICPC

Laceration/cut

1.6

58.0

2444

18114

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

57.4

UKC02

NOMESCO Finland

Cystoscopy

1.9

57.0

931

5221

WF004

NOMESCO Finland

Palliative radiotherapy

151.3

56.9

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

3.1

56.6

329

1093

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

56.3

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

+∞

56.3

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

56.3

R03AC02

ATC

salbutamol; inhalant

1.5

56.2

3171

25091

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.0

55.8

810

4343

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.9

55.6

943

5361

J45.9

ICD-10 Finland

Asthma, unspecified

1.8

55.4

1179

7228

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

4.8

55.3

192

410

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

55.3

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

3.4

54.9

276

825

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

5.2

54.8

178

353

K22.1

ICD-10 Finland

Ulcer of oesophagus

4.6

54.6

196

433

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

3.9

53.9

236

629

EP1AE

NOMESCO Finland

Neck ultrasound examination

3.0

53.9

326

1112

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

3.2

53.7

306

1003

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

11.2

53.7

103

ZXE30

NOMESCO Finland

More than five and less than seven hours

3.0

53.6

322

1095

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

4.1

53.3

219

552

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

53.2

P01AB01

ATC

metronidazole; oral, rectal

1.5

53.1

2368

17682

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

10.9

52.8

103

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

2.8

52.5

354

1298

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.1

52.4

638

3178

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

52.1

ZX070

NOMESCO Finland

Intensity modified radiotherapy

95.8

51.9

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

511.9

51.5

C03CA01

ATC

furosemide; systemic

1.6

51.4

1816

12798

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

23.4

51.4

K22.7

ICD-10 Finland

Barrett oesophagus

6.0

51.4

147

251

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

262.6

51.1

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

51.1

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

51.1

UJK02

NOMESCO Finland

ERCP

4.2

51.0

205

506

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.9

51.0

322

1132

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

178.0

50.9

R01AD09

ATC

mometasone; nasal

1.5

50.8

2586

19835

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

50.6

955

5613

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

501.7

50.5

JLC11

NOMESCO Finland

Laparoscopic distal pancreatectomy

257.3

50.1

X76

ICPC

Malignant neoplasm breast female

257.3

50.1

XW000

NOMESCO Finland

Bone marrow biopsy

3.5

50.1

243

706

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

50.0

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

50.0

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

108.9

49.8

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.9

49.7

318

1126

C07AB07

ATC

bisoprolol; oral

1.5

49.6

3035

24176

L03AA14

ATC

lipegfilgrastim; parenteral

491.5

49.4

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

9.8

49.2

101

104

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

49.0

128

Kela drug reimbursment

Cancers of female genital organs

+∞

49.0

K29.7

ICD-10 Finland

Gastritis, unspecified

3.0

49.0

295

1005

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

131.0

48.8

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.0

48.8

698

3710

ZXA00

NOMESCO Finland

Right side

1.6

48.2

1659

11578

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

47.8

3745

31294

SPAT1263

SPAT

Sampling

1.5

47.6

2558

19760

N05CF01

ATC

zopiclone; oral

1.5

47.4

1968

14354

8936/1-C16.9

ICD-O-3

Gastrointestinal stromal tumor, NOS, of stomach, NOS

471.1

47.4

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

3.8

47.1

206

549

JDA45

NOMESCO Finland

Endoscopic mucosal or submucosal resection in stomach or pylorus

+∞

46.9

JD1EE

NOMESCO Finland

Ultrasound examination of gastro-oesophageal reflux

164.5

46.9

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

3.4

46.2

233

698

GD1AD

NOMESCO Finland

Thorax CT examination

3.1

46.2

265

873

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

45.9

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.1

45.9

541

2655

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

123.4

45.8

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.9

45.4

742

4140

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

36.5

45.3

R53

ICD-10 Finland

Malaise and fatigue

1.7

45.2

1226

8016

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

5.8

44.9

130

226

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

5.4

44.9

138

258

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

44.8

K29.3

ICD-10 Finland

Chronic superficial gastritis

3.0

44.7

272

933

JDA52

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in stomach or pylorus

26.1

44.5

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

7.0

44.4

112

162

UJF02

NOMESCO Finland

Peroral enteroscopy

9.2

44.3

103

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.2

44.3

493

2356

WX892

NOMESCO Finland

Monitored bed care

2.2

44.3

483

2287

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

440.6

44.3

TPX10

NOMESCO Finland

Implantation of vascular injection port

4.5

44.2

163

371

Z2446

NOMESCO Finland

Social worker

2.5

44.2

371

1544

J01AA02

ATC

doxycycline; systemic

1.5

44.1

4805

42592

D01

ICPC

Abdominal pain/cramps general

2.0

44.1

631

3349

A03FA02

ATC

cisapride; oral, rectal

2.1

44.0

567

2887

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

72.1

44.0

ZXD05

NOMESCO Finland

Urgent procedure

1.5

43.8

1749

12588

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

43.8

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.1

43.7

514

2517

J01CA04

ATC

amoxicillin; systemic

1.5

43.7

4725

41765

189

Kela drug reimbursment

Imatinib

430.4

43.2

A06AD11

ATC

lactulose; oral

1.8

43.1

865

5169

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

7.3

43.0

106

148

JFB00

NOMESCO Finland

Partial resection of small intestine

5.5

42.9

130

239

L02BG06

ATC

exemestane; oral

+∞

42.7

R11

ICD-10 Finland

Nausea and vomiting

2.1

42.4

489

2371

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

420.2

42.2

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.5

41.9

206

606

K83.1

ICD-10 Finland

Obstruction of bile duct

7.0

41.8

105

151

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

41.7

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

41.7

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

41.7

E0000UV

ATC

1.5

41.3

2208

16883

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

21.2

41.3

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

211.2

40.9

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

40.9

996

6302

C78.6

ICD-10 Finland

Secondary malignant neoplasm of retroperitoneum and peritoneum

+∞

40.7

21110

ICD-8 Finland

Benign neoplasm of other parts of digestive system, Stomach

+∞

40.7

D02

ICPC

Abdominal pain epigastric

2.3

40.6

386

1712

N06AX11

ATC

mirtazapine; oral

1.5

40.5

1859

13755

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.8

40.3

793

4700

AA1AD

NOMESCO Finland

CT of head and brain

1.5

40.2

1462

10258

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.8

40.2

832

5012

JN1CD

NOMESCO Finland

Very extensive CT examination of upper part of abdomen

8.2

40.1

112

JN5ER

NOMESCO Finland

PET-CT of receptors in whole body

44.8

40.0

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

206.2

39.9

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.9

39.8

663

3713

ZXA05

NOMESCO Finland

Left side

1.5

39.8

1511

10703

E34.0

ICD-10 Finland

Carcinoid syndrome

140.8

39.8

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

39.6

L02BG03

ATC

anastrozole; oral

29.7

39.5

JDA42

NOMESCO Finland

Other endoscopic haemostatic procedure in stomach or pylorus

14.0

39.5

Z01.7

ICD-10 Finland

Laboratory examination

1.8

39.1

690

3943

N03AX12

ATC

gabapentin; oral

1.7

39.1

962

6093

R51.80

ICD-10 Finland

Headache

1.7

39.1

826

5004

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

389.7

39.1

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.1

38.9

457

2233

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

201.1

38.8

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

3.3

38.8

208

654

H02AB07

ATC

prednisone; oral

1.7

38.6

874

5403

L01XE01

ATC

[U] imatinib; oral

+∞

38.6

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

38.6

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

38.5

2780

22445

A07AA02

ATC

nystatin; oral

2.2

38.3

418

1976

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

38.2

2535

20136

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

38.2

438

2117

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

379.5

38.1

L57.0

ICD-10 Finland

Actinic keratosis

2.0

38.0

497

2541

A79

ICPC

Malignancy NOS

46.3

37.8

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

37.8

2142

16498

M79.6

ICD-10 Finland

Pain in limb

1.4

37.7

2141

16491

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.4

37.6

340

1470

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

37.5

B01AB04

ATC

dalteparin; parenteral

2.6

37.5

297

1197

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.0

37.2

525

2762

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

5.3

37.1

116

222

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

37.0

1172

7926

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.6

36.9

291

1170

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.2

36.9

381

1758

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

130.7

36.7

JN1BD

NOMESCO Finland

Extensive CT examination of upper part of abdomen

7.9

36.6

109

JMA10

NOMESCO Finland

Transabdominal total splenectomy

17.2

36.6

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.5

36.6

299

1227

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

36.5

KCD02

NOMESCO Finland

Transurethral resection of bladder

10.7

36.4

R93.2

ICD-10 Finland

Abnormal findings on diagnostic imaging of liver and biliary tract

9.8

36.3

Z71.8

ICD-10 Finland

Other specified counselling

1.5

36.2

1281

8901

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

41.1

36.2

SPAT1153

SPAT

Removal of sutures

1.5

35.6

1799

13500

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

4.1

35.5

142

351

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

35.4

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.3

35.2

336

1491

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.0

35.1

505

2676

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.5

35.0

1434

10288

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

13.7

34.7

Z51.88

ICD-10 Finland

Other specified medical care

3.9

34.7

147

383

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

3.7

34.5

154

419

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

3.3

34.5

182

566

C25.4

ICD-10 Finland

Malignant neoplasm: Endocrine pancreas

+∞

34.4

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

34.4

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

34.4

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

34.4

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

39.4

34.3

ZXC96

NOMESCO Finland

Robot assisted procedure

7.0

34.1

125

C08CA01

ATC

amlodipine; oral

1.4

33.8

2209

17377

TQW99

NOMESCO Finland

Other minor procedure on skin

2.7

33.8

236

885

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

33.7

2435

19501

K83.0

ICD-10 Finland

Cholangitis

4.8

33.7

115

243

R03DC03

ATC

montelukast; oral

1.6

33.6

945

6190

R18

ICD-10 Finland

Ascites

4.9

33.6

112

231

M04AA01

ATC

allopurinol; systemic

1.7

33.4

724

4404

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

11.3

33.4

C16.00

ICD-10 Finland

Cardia

+∞

33.3

8140/3-C25.9

ICD-O-3

Adenocarcinoma, NOS, of pancreas, NOS

+∞

33.3

8097/3-C44.9

ICD-O-3

Basal cell carcinoma, nodular of skin, NOS

+∞

33.3

8240/3-C16.9

ICD-O-3

Neuroendocrine tumor, NOS, of stomach, NOS

+∞

33.3

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

33.3

C25.2

ICD-10 Finland

Malignant neoplasm: Tail of pancreas

+∞

33.3

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.0

33.1

443

2283

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

41.2

33.0

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

33.0

1316

9367

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

63.6

33.0

C03DA01

ATC

spironolactone; oral

1.7

33.0

682

4091

ZXE40

NOMESCO Finland

More than seven and less than nine hours

3.6

32.9

151

421

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

32.9

2638

21489

J01FA10

ATC

azithromycin; systemic

1.4

32.9

3165

26593

M54.5

ICD-10 Finland

Low back pain

1.4

32.8

1857

14200

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.1

32.7

395

1952

R31

ICD-10 Finland

Unspecified haematuria

1.9

32.7

515

2819

TQW20

NOMESCO Finland

Tatoe

49.0

32.5

ZX112

NOMESCO Finland

Subcutaneous

6.4

32.5

138

J01MA14

ATC

moxifloxacin; systemic

1.9

32.4

501

2725

R06AE07

ATC

cetirizine; oral

1.4

32.3

2395

19226

8170/3-C22.0

ICD-O-3

Hepatocellular carcinoma, NOS, of liver

+∞

32.3

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

32.3

K92.0

ICD-10 Finland

Haematemesis

3.2

32.2

177

567

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

32.2

1035

6999

R12

ICD-10 Finland

Heartburn

2.0

32.1

448

2346

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

32.0

1296

9249

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.2

31.9

170

533

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

318.5

31.9

Z71.9

ICD-10 Finland

Counselling, unspecified

2.1

31.7

357

1712

C44.11

ICD-10 Finland

Basocellular carcinoma of the skin of the eyelids including the corner of the eye

113.9

31.7

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

31.5

416

2131

J01FA06

ATC

roxithromycin; oral

1.4

31.4

2353

18897

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.1

31.3

101

201

8720/3-C44.5

ICD-O-3

Malignant melanoma, NOS, of skin of trunk

+∞

31.3

A10AE04

ATC

insulin glargine; parenteral

1.8

31.2

571

3292

N05BA04

ATC

oxazepam; oral

1.5

31.2

1406

10257

Z31.5

ICD-10 Finland

Genetic counselling

2.8

31.0

206

749

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

31.0

2178

17284

G44.2

ICD-10 Finland

Tension-type headache

1.7

31.0

754

4738

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

30.9

2040

16008

H01CB02

ATC

octreotide; parenteral

33.5

30.9

JN3DG

NOMESCO Finland

Very extensive MRI examination with high intensity magnet

23.3

30.8

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

314.3

30.8

C90.0

ICD-10 Finland

Multiple myeloma

160.7

30.7

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

30.6

445

2366

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

5.3

30.5

182

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

30.5

588

3446

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

11.5

30.5

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.5

30.4

249

1020

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

30.2

R01AD08

ATC

fluticasone; nasal

1.4

30.2

1544

11542

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

29.9

287

1276

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

68.2

29.9

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

29.6

574

3368

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

5.9

29.6

144

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

23.5

29.5

RD210

NOMESCO Finland

3.9

29.3

123

319

XF404

NOMESCO Finland

Ambulatory ECG

1.8

29.2

582

3447

3AC01

NOMESCO Finland

4.8

29.2

100

213

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

29.2

8240/3-C25.9

ICD-O-3

Neuroendocrine tumor, NOS, of pancreas, NOS

+∞

29.2

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

29.2

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

29.2

1461

10864

D50.8

ICD-10 Finland

Other iron deficiency anaemias

4.1

29.1

116

287

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

29.0

778

5016

D70.82

ICD-10 Finland

Drug-induced neutropenia

8.9

29.0

R05

ICD-10 Finland

Cough

1.5

29.0

1116

7854

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

293.2

28.8

R03BA02

ATC

budesonide; inhalant

1.5

28.8

1005

6919

N06AB04

ATC

citalopram; systemic

1.5

28.8

1234

8888

WX004

NOMESCO Finland

Patient-controlled sedation

7.9

28.7

B80

ICPC

Iron deficiency anaemia

3.4

28.6

143

428

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

3.9

28.6

120

311

J01DA01

ATC

[U] cefalexin; systemic

1.3

28.4

3642

31707

S77

ICPC

Malignant neoplasm of skin

26.1

28.3

XJH00

NOMESCO Finland

Transanal ultrasonography

2.2

28.3

297

1381

JFB30

NOMESCO Finland

Right hemicolectomy

7.9

28.3

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

28.2

429

2319

C25.1

ICD-10 Finland

Malignant neoplasm: Body of pancreas

+∞

28.1

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

28.1

JCC12

NOMESCO Finland

Thoracoscopic or laparoscopic partial oesophagectomy

+∞

28.1

2115X

ICD-9 Finland

Benign neoplasm of other parts of digestive system, Liver and biliary passages[NEOPLASMA BENIGNUM ALIUD HEPATIS, VESIC FELLEAE ET]

+∞

28.1

AA1BD

NOMESCO Finland

Extensive CT of head and brain

3.4

28.1

142

429

ZZR00

NOMESCO Finland

Flap of skin

6.4

28.1

119

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

28.0

1459

10917

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.0

28.0

399

2106

C10AC01

ATC

colestyramine; oral

2.8

27.9

185

673

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.9

27.9

434

2364

TKE00

NOMESCO Finland

Needle biopsy of prostate

3.3

27.9

143

437

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

282.6

27.8

SPAT1301

SPAT

No procedures

1.4

27.6

1838

14379

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.5

27.4

219

889

JKA20

NOMESCO Finland

Cholecystectomy

2.8

27.0

183

675

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

27.0

1750

13616

K59.09

ICD-10 Finland

Constipation, unspecified

2.0

27.0

371

1931

JCA45

NOMESCO Finland

Endoscopic mucosal or submucosal resection in oesophagus

62.3

26.9

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3013650) Neutrophils [#/volume] in Blood by Automated count

4790

31120

2.61

312.87

10.8

6.4

e9/l

4.3

4.2

0.03

4264

26639

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5092

27730

3.85

307.65

8.1

3.7

umol/l

11.6

0.01

4890

25869

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

685

637

11.78

307.65

3.0

1.8

u/ml

615.4

241.5

0.32

626

572

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1765

3055

7.33

307.65

3.3

1.4

ug/l

4.8

8.2

0.39

1400

2270

(3024561) Albumin [Mass/volume] in Serum or Plasma

4391

24002

3.12

307.65

6.8

3.7

g/l

35.2

35.7

8.54

4141

21854

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3488

18148

2.79

307.65

3.5

2.2

u/l

58.0

58.6

0.21

3267

16558

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

969

1041

10.60

307.65

3.4

1.7

u/ml

714.2

211.0

0.36

830

831

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

448

305

15.60

307.65

4.4

1.6

nmol/l

7.5

4.0

1.70

436

292

(3032080) INR in Blood by Coagulation assay

3993

23469

2.57

307.65

10.8

9.7

inr

1.2

1.3

1.92

976

6611

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1512

4179

4.31

307.65

2.8

2.0

g/l

0.2

11.70

1426

3787

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6185

44241

3.82

307.65

11.0

5.4

u/l

83.4

75.7

19.96

5951

40859

(4035726)

948

1710

6.23

307.65

1.4

1.2

—

(40768797) Stomach Pathology biopsy report

2657

8135

4.59

307.65

1.7

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1671

5821

3.44

307.65

3.6

2.1

umol/l

7.9

7.5

0.26

1475

4971

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1340

4777

3.22

287.33

3.5

2.2

u/l

80.9

47.9

0.80

1161

4033

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

157

66.85

287.02

3.5

2.0

pmol/l

64.3

73.2

0.23

138

(3033658) Prothrombin time (PT) actual/Normal

2616

13437

2.49

276.01

5.9

3.4

89.6

88.9

0.68

2560

13050

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2787

14757

2.45

274.77

3.1

2.3

mg/l

3.4

2.9

13.31

2441

12540

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

4463

29141

2.40

270.65

8.8

5.5

mmol/l

1.2

5.87

3882

24423

(40768804) Tissue Pathology biopsy report

3364

19620

2.34

263.02

2.5

1.7

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1926

8898

2.59

250.85

3.3

2.5

umol/l

11.8

12.9

10.09

1793

8119

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3914

24675

2.28

250.08

5.1

3.6

—

(3001604) Monocytes [#/volume] in Blood

4298

28262

2.29

246.69

7.2

5.4

e9/l

0.6

0.25

3770

24178

(3006315) Basophils [#/volume] in Blood

4308

28439

2.28

243.71

7.2

5.4

e9/l

0.0

0.47

3782

24337

(3014576) Chloride [Moles/volume] in Serum or Plasma

1585

6773

2.72

240.63

8.4

6.3

mmol/l

104.4

104.2

0.71

1569

6611

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

4064

26289

2.25

240.27

8.0

5.1

mmol/l

1.2

7.45

3771

23213

(3019198) Lymphocytes [#/volume] in Blood

4351

29072

2.25

235.68

7.3

5.5

e9/l

1.9

0.05

3881

25339

(3044640) Blood type and Crossmatch panel - Blood

2861

16139

2.28

235.22

3.2

2.1

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1692

7545

2.62

235.22

3.5

2.6

20.5

22.3

5.72

1475

6281

(3013115) Eosinophils [#/volume] in Blood

4387

29430

2.26

235.02

7.6

5.6

e9/l

0.2

2.95

3913

25589

(3013826) Glucose [Moles/volume] in Serum or Plasma

4876

34196

2.32

234.01

6.6

4.2

mmol/l

6.8

0.70

4653

31771

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1774

8134

2.57

232.48

3.4

2.5

g/l

2.4

2.3

2.60

1657

7433

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3791

24243

2.19

225.33

4.3

2.8

ug/l

114.4

120.3

0.88

3540

22217

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3017

17646

2.22

224.39

4.1

2.6

u/l

32.7

33.6

0.36

2875

16565

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1766

8228

2.52

222.54

3.9

2.4

mmol/l

0.8

4.43

1655

7526

(40758558) Short blood count panel - Blood

2391

13076

2.24

206.14

8.3

4.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

3064

18490

2.14

205.70

3.8

2.1

mmol/l

2.3

2.4

3.03

2696

15394

(3002256) Pathology report gross observation

1175

4704

2.79

199.34

1.4

1.1

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

614

1657

3.96

198.93

1.5

1.4

ug/g

246.3

292.5

5.86

397

953

(3018418) pH of Serum or Plasma

2851

16975

2.12

195.76

5.4

3.2

7.4

0.15

464

2961

(3010370) Gastrin [Moles/volume] in Serum or Plasma

135

25.00

192.07

2.0

1.5

pmol/l

69.6

37.8

1.79

116

(36304419) Bacteria [Presence] in Urine

2613

15137

2.14

191.90

3.9

2.9

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1268

5413

2.63

188.73

4.4

2.7

u/l

232.2

239.8

1.60

1188

5007

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1512

7020

2.46

188.45

6.9

5.1

mmol/l

1.0

0.10

1414

6438

(3030467) Casts [#/volume] in Urine by Automated count

2670

15681

2.12

188.36

4.0

2.9

e6/l

0.5

0.4

0.29

2113

11614

(3022145) Colonoscopy Study observation

1367

6060

2.55

188.13

1.4

1.3

—

(3019069) Monocytes/100 leukocytes in Blood

3891

26342

2.04

184.85

7.8

5.9

8.6

0.13

3668

24336

(3006504) Eosinophils/100 leukocytes in Blood

3874

26205

2.03

184.25

7.5

5.6

2.8

2.9

2.01

3652

24083

(42870588) Differential panel, method unspecified - Blood

3041

18907

2.05

182.46

6.9

5.5

—

(3022096) Basophils/100 leukocytes in Blood

3779

25423

2.02

181.51

7.4

5.7

0.7

0.73

3561

23386

(3031040) Bacteria [#/volume] in Urine by Automated count

5163

38946

2.15

180.07

6.1

4.4

e6/l

133.1

2166.9

7.69

556

(3002030) Lymphocytes/100 leukocytes in Blood

3941

26982

2.02

179.28

7.6

5.7

26.7

27.9

9.06

3699

24770

(3023368) Bacteria identified in Blood by Culture

2505

14631

2.09

176.89

5.3

3.8

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2208

12346

2.14

174.53

3.1

2.1

—

(3018095) Leukocytes [#/volume] in Urine

3161

20177

2.01

173.79

4.9

3.4

e6/l

81.3

109.1

0.90

2385

13942

(3027945) Reticulocytes/100 erythrocytes in Blood

1379

6378

2.44

171.77

2.5

2.1

1.8

0.99

1227

5540

(3018010) Neutrophils/100 leukocytes in Blood

3878

26726

1.98

169.37

7.4

5.6

58.3

57.4

5.22

3641

24668

(3002582) Erythrocytes [#/volume] in Urine

2762

17018

2.01

165.82

4.2

3.0

e6/l

69.0

81.0

0.27

2219

12811

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3804

26499

1.92

155.93

2.4

2.0

pmol/l

93.4

96.2

2.51

2119

13263

(3026782) Osmolality of Urine

1957

10842

2.11

155.47

3.4

2.6

mosm/kgh2o

522.3

539.4

2.90

1665

9037

(3000850) Epithelial cells [#/volume] in Urine

2078

11857

2.06

151.88

3.1

2.4

e6/l

5.0

5.5

1.21

1815

10212

(3013707) Erythrocyte sedimentation rate by Westergren method

5585

44882

2.09

143.93

5.3

4.2

mm/h

14.1

12.3

13.35

5224

41380

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1755

9700

2.07

137.86

3.2

2.5

e6/l

1.5

1.2

0.64

1043

5568

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1858

10511

2.03

136.76

3.5

2.2

mmol/l

2.5

1.53

1647

8969

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1611

8675

2.10

135.41

2.7

1.9

30.3

29.9

1.29

1572

8382

(3021589) Normoblasts [#/volume] in Blood

3566

25156

1.83

132.20

12.7

8.5

e9/l

0.0

0.07

2981

20513

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1600

8736

2.07

128.77

3.5

2.7

e6/l

2.7

3.0

0.49

901

4651

(3037467) Urinalysis macro (dipstick) panel - Urine

5157

40974

1.91

127.85

5.6

4.3

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1265

6347

2.20

126.64

8.3

6.7

kpa

5.1

0.09

1211

6043

(3027801) Oxygen [Partial pressure] in Arterial blood

1264

6343

2.20

126.47

8.3

6.7

kpa

12.3

11.7

3.61

1211

6029

(3023520) Reticulocytes [#/volume] in Blood

1031

4781

2.35

124.49

2.4

2.1

e9/l

69.6

69.5

0.05

786

3629

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1080

5115

2.31

124.13

9.0

7.5

g/l

118.2

122.1

7.96

1048

4913

(3003396) Base excess in Arterial blood by calculation

1252

6309

2.19

123.73

8.3

6.7

mmol/l

1.1

1.3

1.39

1028

4888

(3000991) Gas panel - Venous blood

970

4392

2.40

123.60

9.9

7.8

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6675

58857

2.83

120.68

24.1

12.7

mg/l

24.6

22.7

4.80

5739

45840

(3020779) Urea [Moles/volume] in Serum or Plasma

1008

4705

2.33

119.57

9.5

6.8

mmol/l

10.1

10.5

1.00

955

4441

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

881

3883

2.45

118.93

1.8

1.6

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1805

10624

1.93

115.56

1.6

1.3

g/l

2.5

0.21

1095

6110

(3016502) Oxygen saturation in Arterial blood

1139

5680

2.19

114.84

8.7

7.1

95.8

95.2

2.86

1107

5450

(3048689) Calprotectin [Mass/mass] in Stool

1294

6783

2.11

114.74

2.2

ug/g

138.3

137.1

0.05

1036

5261

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3489

25148

1.75

114.03

2.8

2.2

nmol/l

78.3

78.8

0.55

3128

22153

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

4705

36960

1.79

113.24

4.3

2.9

u/l

61.3

45.2

16.64

4399

33923

(40768441) Liver Pathology biopsy report

167

237

7.19

111.54

1.4

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

857

3837

2.40

111.35

2.7

2.3

g/l

10.3

10.7

2.31

787

3512

(3014111) Lactate [Moles/volume] in Serum or Plasma

986

4719

2.26

109.62

8.2

6.4

mmol/l

1.3

1.4

1.47

942

4548

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

771

3321

2.48

108.97

9.9

8.6

0.7

0.12

766

3298

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

642

2555

2.66

106.87

1.8

1.6

g/l

1.5

1.6

0.05

544

2183

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

771

3353

2.46

106.62

9.8

8.5

1.3

1.4

4.89

766

3328

(3044889) 12 lead EKG panel

5183

42258

1.81

105.84

5.0

3.9

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1998

12442

1.84

105.78

1.9

1.8

nmol/l

1192.5

1164.3

0.63

1561

9305

(3021960) Folate [Moles/volume] in Serum or Plasma

2287

14834

1.79

105.78

1.7

1.5

nmol/l

21.3

20.7

0.70

2027

12472

(3042936) Bacteria identified in Isolate by Culture

1366

7556

2.00

103.44

2.4

2.0

—

(3009261) Glucose [Presence] in Urine by Test strip

3915

29681

1.70

101.93

4.9

3.8

estimate

0.0

2.28

622

4979

(3035350) Ketones [Presence] in Urine by Test strip

3872

29303

1.69

101.17

4.9

3.7

estimate

0.0

0.80

613

5051

(3021601) Nitrite [Presence] in Urine by Test strip

3873

29355

1.69

100.23

6.5

5.0

estimate

0.0

1.08

637

5110

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

2002

12698

1.80

98.51

1.3

1.2

u/ml

1.4

1.8

0.46

550

3383

(3026008) Bacteria identified in Urine by Culture

2687

18558

1.71

97.78

3.7

3.2

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

937

4667

2.16

93.43

4.4

3.5

ng/l

96.7

90.9

1.00

803

3925

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1990

12788

1.77

92.63

2.2

1.7

mg/l

1.2

0.07

1559

9750

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1880

11963

1.77

90.11

4.5

3.8

ng/l

425.1

484.5

0.17

1506

9491

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

291

825

3.63

86.74

1.2

1.3

—

(3020630) Protein [Mass/volume] in Serum or Plasma

926

4725

2.10

86.29

2.5

1.6

g/l

65.8

66.8

3.72

849

4196

(3028026) IgM [Mass/volume] in Serum or Plasma

673

3038

2.34

84.82

1.8

1.5

g/l

1.4

1.2

0.87

626

2756

(3017143) Hepatitis C virus Ab [Presence] in Serum

941

4904

2.06

82.63

1.7

1.5

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1133

6315

1.94

82.14

2.0

1.7

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

372

1280

3.01

80.94

3.9

2.5

g/l

3.7

3.5

1.17

358

1193

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3183

23776

1.61

80.47

4.5

3.7

ng/l

34.1

81.0

2.51

2246

16604

(3021447) Carbon dioxide [Partial pressure] in Venous blood

992

5323

2.00

80.15

4.8

3.6

kpa

5.8

0.29

964

5163

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2622

18726

1.63

79.45

3.4

3.0

ng/l

1517.5

1414.1

0.50

2277

16097

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

620

2777

2.35

79.38

10.0

9.5

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2115

14315

1.68

79.15

4.8

3.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

6762

61918

2.50

78.41

27.8

15.3

mmol/l

139.5

139.8

17.37

6664

60210

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1117

6303

1.91

77.68

2.0

1.7

—

(3002032) Base excess in Venous blood by calculation

980

5314

1.98

76.61

4.8

3.6

mmol/l

1.9

2.0

0.33

816

4335

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1475

9139

1.77

75.59

2.1

1.7

—

(3012544) pH of Venous blood

1005

5528

1.95

75.26

4.8

3.6

7.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

883

4643

2.03

75.22

3.0

2.4

ml/min/173m2

63.3

63.4

0.02

393

1774

(3023103) Potassium [Moles/volume] in Serum or Plasma

6763

62087

2.46

75.17

28.0

15.4

mmol/l

4.0

9.78

6656

60258

(3026493) Urate [Moles/volume] in Serum or Plasma

2258

15778

1.63

73.36

3.3

2.4

umol/l

3061.7

5375.9

2.48

1953

13425

(3036481) Cortisol [Moles/volume] in Serum or Plasma

914

4921

1.98

72.68

2.5

1.8

nmol/l

363.5

367.6

0.24

824

4438

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

422

1644

2.66

72.66

3.2

3.3

u/ml

0.3

0.4

1.70

237

958

(3007853) Bacteria identified in Skin by Aerobe culture

1132

6570

1.86

71.65

2.0

1.8

—

(3007566) Smooth muscle Ab [Titer] in Serum

397

1510

2.72

71.65

1.3

1.2

titre

95.2

144.0

0.56

133

(3002385) Erythrocyte distribution width [Ratio]

5544

47935

1.68

71.61

29.6

15.2

14.1

13.7

51.79

5471

46748

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

700

3438

2.15

71.39

2.7

2.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5430

46745

1.66

70.81

4.9

4.0

pmol/l

14.9

0.17

5013

42242

(3014765) Yersinia sp identified in Stool by Organism specific culture

413

1624

2.64

69.76

1.3

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

370

1382

2.77

69.13

3.1

2.1

92.7

91.9

0.28

351

1277

(42529406) Shigella sp [Presence] in Stool by Culture

413

1635

2.62

68.80

1.3

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

275

878

3.22

67.92

1.9

1.6

g/l

0.7

0.8

0.42

214

657

(40760892) CBC W Ordered Manual Differential panel - Blood

1801

12089

1.65

67.68

5.0

4.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

407

1613

2.61

67.64

1.3

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

832

4460

1.98

66.67

3.8

3.1

kpa

4.5

0.00

805

4319

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

586

2761

2.22

66.16

10.6

8.7

mmol/l

24.4

24.5

0.27

542

2531

(3037522) Nuclear Ab [Titer] in Serum

1315

8173

1.74

65.60

1.4

1.3

titre

537.7

543.2

0.04

296

1832

(3034770) Mitochondria Ab [Titer] in Serum

388

1529

2.63

65.20

1.3

1.2

titre

612.5

1022.7

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

11.89

65.19

6.7

1.3

—

(40768793) Breast Pathology biopsy report

168

395

4.33

64.93

1.3

1.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

650

3215

2.12

64.86

1.6

1.4

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

485

2135

2.36

64.26

2.8

1.5

u/ml

55.6

27.9

0.48

458

2037

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

344

1285

2.76

64.21

4.3

2.3

204.3

187.2

2.70

325

1209

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2621

19497

1.54

62.60

2.3

2.1

u/l

162.7

218.1

2.82

2496

18124

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

998

5801

1.84

62.18

1.7

1.5

—

(40761511) CBC panel - Blood by Automated count

6654

61351

2.11

61.87

22.5

12.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

30.94

60.99

1.1

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

482

2166

2.31

60.83

1.7

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

763

4153

1.94

58.06

1.2

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

694

3675

1.98

57.19

8.1

6.8

mmol/l

24.6

0.22

654

3401

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

307

1151

2.74

56.86

1.7

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

235

760

3.16

56.79

8.7

4.9

iu/ml

3343.1

927.6

0.42

100

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

531

2574

2.15

55.57

6.1

4.0

mmol/l

24.1

24.3

0.33

469

2284

(3019060) Gas panel - Arterial blood

713

3849

1.95

55.49

5.5

4.7

—

(3036489) Thrombin time

420

1852

2.35

55.29

2.9

1.9

22.2

21.3

1.04

376

1598

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

6152

55754

1.71

54.52

6.1

4.8

mu/l

1.9

2.0

2.59

5750

50717

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

190

557

3.48

53.79

3.2

2.4

u/ml

1268.1

610.6

0.31

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

217

696

3.18

53.18

1.1

g/l

1.5

0.53

196

609

(3020891) Body temperature

494

2376

2.16

52.68

5.5

4.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

951

5706

1.77

52.67

2.7

2.4

ug/l

5.5

7.4

3.20

834

4925

(3004588) Protein electrophoresis panel - Serum or Plasma

741

4127

1.89

52.34

2.1

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

446

2077

2.22

51.53

2.2

1.8

ug/l

3.0

1.9

1.00

386

1802

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6754

63205

2.10

50.99

16.0

9.1

u/l

26.3

25.3

4.50

6611

60443

(3022217) INR in Platelet poor plasma by Coagulation assay

1278

8381

1.64

50.70

31.6

27.7

inr

1.4

0.09

1156

(3019150) Specific gravity of Urine by Refractometry

1860

13323

1.53

50.44

5.6

4.2

kg/l

1.0

1.31

297

1964

(40768800) Prostate Pathology biopsy report

130

305

4.32

50.42

1.2

1.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

5829

52400

1.59

49.99

26.8

14.1

38.5

39.5

12.55

3882

35398

(3021879) Hepatitis B virus core Ab [Presence] in Serum

584

3047

2.00

49.98

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

915

5530

1.75

49.19

3.3

2.9

ng/l

205.5

203.4

0.05

825

5073

(3025941) Bacteria identified in Stool by Culture

588

3093

1.98

49.14

1.5

1.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

9.14

48.60

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

237

846

2.86

48.14

1.3

1.2

—

(3018405) Lactate [Moles/volume] in Arterial blood

438

2083

2.17

47.98

4.8

4.0

mmol/l

1.3

1.4

0.55

430

2043

(1617658) Protocol used for examination of sentinel lymph nodes

87.36

46.86

1.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

504

2560

2.04

46.40

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2861

22650

1.44

45.77

5.3

4.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

266

1046

2.60

44.79

3.4

2.6

umol/l

35.3

34.2

0.23

226

898

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

347

1545

2.31

44.57

1.3

1.2

—

(40761535) Cells panel - Urine sediment

855

5230

1.72

43.71

4.6

3.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

8.42

43.27

1.8

2.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

1050

6798

1.64

43.21

1.8

1.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

460

2321

2.05

43.07

2.1

1.4

g/l

7.3

7.5

0.95

331

1686

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

459

2316

2.05

42.97

2.1

1.4

g/l

3.7

3.8

0.71

321

1621

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

6091

55809

1.59

42.88

21.3

11.7

ml/min/173m2

77.3

77.6

0.51

5276

44986

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

457

2317

2.04

42.21

2.1

1.4

—

(3003327) Ova and parasites identified in Stool by Light microscopy

382

1815

2.17

41.88

1.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

433

2169

2.06

41.32

2.1

1.5

g/l

3.1

0.54

323

1654

(3042111) Morphology [Interpretation] in Bone marrow Narrative

196

687

2.90

41.19

1.5

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1233

8391

1.57

40.97

1.5

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

398

1938

2.12

40.96

2.2

1.5

g/l

0.7

0.5

0.67

345

1638

(3003694) ABO and Rh group [Type] in Blood

1848

13709

1.47

40.67

1.4

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

362

1705

2.18

40.56

2.2

1.5

g/l

0.0

0.02

328

1548

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

120

313

3.88

40.41

1.6

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

217

4.52

40.02

4.9

1.2

u/ml

293.7

185.6

0.29

(3052851) Hemolysis interference index of Serum or Plasma

356

1683

2.17

39.51

3.5

3.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1193

8119

1.56

39.49

12.1

6.8

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

633

3657

1.80

39.30

4.1

3.2

g/l

123.5

130.1

10.62

616

3548

(3017181) Myelocytes/100 leukocytes in Blood

749

4555

1.72

38.88

4.5

3.8

1.1

0.7

1.35

186

948

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

271

1150

2.41

38.82

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

271

1150

2.41

38.82

1.4

1.3

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

302

1356

2.28

38.01

1.4

1.3

—

(3012516) Albumin [Mass/volume] in Urine

2462

19457

1.40

37.64

3.5

3.2

mg/l

601.0

342.1

1.47

1585

11961

(3009508) Creatinine [Moles/volume] in Urine

2530

20096

1.40

37.51

3.4

3.1

mmol/l

7.0

7.2

1.96

2144

16814

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

236

955

2.52

37.47

1.7

1.5

—

(3035637) Corticotropin [Mass/volume] in Plasma

153

496

3.13

36.89

1.6

1.4

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

329

1556

2.17

36.46

2.2

1.5

g/l

0.0

0.00

301

1425

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

359

1757

2.10

36.42

2.8

2.9

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

418

2164

1.99

36.34

2.1

1.5

g/l

10.1

10.3

0.44

348

1785

(3000494) Fungus identified in Specimen by Culture

1011

6742

1.58

36.31

1.7

1.4

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

333

1586

2.15

36.25

2.2

1.5

g/l

0.0

0.00

301

1432

(4010399)

745

4625

1.68

35.68

1.5

1.4

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

3882

33222

1.37

35.63

2.9

2.6

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

497

2748

1.87

35.48

3.8

2.7

0.7

0.14

475

2621

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

164

567

2.94

35.37

1.2

1.1

u/l

54.4

60.6

0.71

126

356

(44790047)

156

527

3.00

35.05

1.8

1.4

—

(44806118)

156

527

3.00

35.05

1.8

1.4

—

(44790049)

156

527

3.00

35.05

1.8

1.4

—

(44790048)

156

527

3.00

35.05

1.8

1.4

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2553

20499

1.38

34.75

4.2

4.0

mg/mmol

12.7

8.7

2.64

1627

12615

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

217

4.23

34.65

2.1

2.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

250

1079

2.36

34.49

1.6

1.4

—

(3011412) CD3 cells [#/volume] in Blood

112

314

3.61

34.03

2.1

2.2

e9/l

1.2

1.1

0.74

176

(3043409) Potassium [Moles/volume] in Arterial blood

358

1796

2.05

33.97

5.2

4.3

mmol/l

3.8

3.9

1.13

351

1694

(3024139) IgG subclass 3 [Mass/volume] in Serum

162

571

2.88

33.75

1.5

1.4

g/l

0.4

0.58

117

396

(3028192) IgG subclass 2 [Mass/volume] in Serum

162

571

2.88

33.75

1.5

1.4

g/l

2.8

2.9

0.29

117

392

(3027135) IgG subclass 1 [Mass/volume] in Serum

162

572

2.87

33.64

1.5

1.4

g/l

6.1

6.8

1.92

117

395

(4062490)

161

570

2.87

33.27

1.5

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

359

1817

2.03

33.24

2.1

1.4

g/l

37.4

37.7

0.41

314

1516

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

205

825

2.53

32.95

1.4

1.2

nmol/l

0.6

3.8

1.00

190

797

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

6109

56749

1.50

32.60

7.7

6.1

mmol/mol

41.0

40.2

9.31

5735

52234

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

576

3418

1.74

32.44

3.3

3.0

pmol/l

4.4

0.73

510

2971

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

204

829

2.50

32.13

1.4

1.2

nmol/l

0.3

0.04

(3020961) Endomysium IgA Ab [Titer] in Serum

469

2631

1.84

31.92

1.1

titre

61.4

186.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

137

5.00

31.86

3.1

2.6

e6/l

331.4

584.5

0.70

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

498

2849

1.80

31.78

1.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

698

4388

1.65

31.70

4.5

3.8

0.2

0.1

0.68

170

882

(3029937) Albumin [Presence] in Urine by Test strip

2041

15996

1.39

31.47

5.7

4.2

estimate

0.0

1.74

613

5019

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

190

754

2.56

31.45

1.4

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

249

1120

2.27

31.22

1.6

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

361

1872

1.98

31.21

2.7

1.6

mg/l

37.3

37.5

0.02

309

1493

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

231

3.93

31.07

2.0

2.1

15.0

15.3

0.06

103

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

193

777

2.52

31.01

1.6

1.4

—

(1175426) CD3 cells/100 lymphocytes in Blood

238

3.86

30.61

2.0

2.1

71.9

72.6

0.14

225

(3034860) Kappa light chains.free [Mass/volume] in Serum

359

1877

1.96

30.30

2.7

1.6

mg/l

62.3

46.1

0.71

306

1501

(3025159) Blasts/100 leukocytes in Blood

667

4193

1.65

30.24

4.4

3.9

0.0

0.3

1.07

142

781

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

350

1821

1.97

29.96

2.7

1.5

ratio

2.5

2.1

0.17

159

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

183

731

2.54

29.90

1.5

1.4

u/ml

105.3

122.8

0.94

143

(3049717) Cytology report of Urine Cyto stain

339

1747

1.99

29.83

2.9

1.8

—

(40768795) Lymph node Pathology biopsy report

123

5.08

29.58

1.3

1.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

301

1492

2.06

29.51

1.7

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

197

821

2.44

29.41

1.5

1.4

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

462

2654

1.79

29.04

1.5

u/ml

7.4

17.5

—

(36660697) Celiac disease serology panel - Serum

713

4609

1.61

28.83

1.3

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

550

3339

1.70

28.43

1.8

1.6

—

(3007461) Platelets [#/volume] in Blood

6837

65568

1.84

28.37

36.7

18.9

e9/l

252.1

250.2

1.38

6724

63579

(4281824)

107

329

3.29

28.24

1.4

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

117

5.08

28.17

2.7

2.3

e6/l

2219.0

30597.4

0.89

(3003338) MCHC [Mass/volume]

5388

49282

1.37

28.17

33.3

16.7

g/l

330.2

331.9

35.81

5349

48916

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

163

634

2.61

28.15

7.3

6.5

mg/l

11.8

11.9

0.11

150

568

(3035941) MCH [Entitic mass]

6838

65595

1.84

28.14

36.5

18.8

30.1

30.4

33.89

6773

64439

(3024731) MCV [Entitic volume]

6838

65595

1.84

28.14

36.6

18.8

90.9

91.3

9.73

6773

64438

(3026361) Erythrocytes [#/volume] in Blood

6838

65602

1.84

28.02

36.7

18.9

e12/l

4.4

4.5

50.82

6703

63387

(3000963) Hemoglobin [Mass/volume] in Blood

6839

65616

1.84

28.00

36.9

19.0

g/l

130.5

135.4

134.68

6769

64474

(3010813) Leukocytes [#/volume] in Blood

6838

65612

1.83

27.86

36.7

18.9

e9/l

6.9

6.7

6.94

6702

63383

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

167

4.28

27.58

2.5

2.6

42.0

44.6

0.47

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

159

4.37

27.52

3.6

2.3

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

102

310

3.32

27.44

1.3

1.2

u/l

26.2

21.4

0.48

256

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

261

1262

2.11

27.34

4.0

2.7

mg/l

1.8

1.6

1.94

243

1127

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

335

1779

1.93

27.00

1.5

1.6

g/l

1.2

0.55

318

1666

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

329

1737

1.94

26.98

1.5

1.6

g/l

0.2

0.38

309

1635

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

103

321

3.24

26.62

1.3

1.2

u/l

94.7

85.8

0.46

269

(3026692) Albumin [Mass/volume] in Peritoneal fluid

105

5.17

26.38

1.9

g/l

11.4

13.1

0.60

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

264

3.48

26.34

1.1

1.0

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

222

3.72

26.31

2.1

2.2

e9/l

0.2

0.05

196

(3006245) CD3-CD19+ cells/100 cells in Blood

113

4.99

26.23

2.1

2.2

9.8

8.3

0.34

105

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

6284

59223

1.48

26.09

5.7

4.8

mmol/l

6.1

6.0

9.84

5821

53678

(3038177) Helicobacter pylori Ab [Presence] in Serum

195

856

2.31

25.94

1.3

1.2

—

(40760888) Immunoglobulin light chains.free panel - Serum

274

1381

2.02

25.68

2.7

1.5

—

(3000492) Spirometry study

784

5314

1.53

25.64

1.6

1.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

487

2941

1.70

25.62

3.7

3.1

mmol/l

25.2

25.3

0.14

475

2830

(3048929) Epstein Barr virus Ab [Presence] in Serum

243

1174

2.11

25.53

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1766

13904

1.36

25.42

1.9

1.7

pmol/l

12636326.0

33139966.9

1.35

1472

11352

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1415

10764

1.39

25.20

1.3

iu/ml

29.3

34.2

0.79

419

3396

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

132

491

2.72

24.95

1.5

1.4

—

(3033799) Differential panel - Peritoneal fluid

115

4.81

24.73

2.7

2.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

704

4698

1.55

24.67

4.8

2.9

mmol/l

1.2

0.48

641

3934

(3002179) Metamyelocytes/100 leukocytes in Blood

643

4206

1.58

24.60

4.1

3.6

0.5

0.02

126

714

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

207

954

2.20

24.53

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

262

3.39

24.50

3.2

3.0

mu/l

20.0

25.0

0.98

249

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

241

1180

2.08

24.45

2.4

1.6

nmol/l

0.8

0.55

211

973

(3013512) EKG study

2211

18081

1.32

24.40

4.8

4.0

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

194

877

2.25

24.10

1.5

1.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

158

655

2.44

23.93

1.6

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

413

2431

1.74

23.82

1.8

1.9

u/l

39.3

39.1

0.06

353

2099

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

122

447

2.76

23.75

1.5

1.4

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

234

3.49

23.64

2.1

e6/l

491.3

437.6

0.59

199

(3045142) Bone marrow Pathology biopsy report

109

377

2.92

23.61

1.3

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1343

10240

1.38

23.37

1.3

u/ml

15.8

13.7

0.24

534

3858

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

123

457

2.72

23.32

1.3

1.2

titre

262.6

153.0

0.63

(21494890) Protein electrophoresis panel - 24 hour Urine

136

535

2.57

23.02

1.8

1.3

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

100

338

2.99

22.59

1.7

1.5

u/l

5.6

7.6

0.55

144

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

360

2079

1.77

22.19

1.7

1.6

titre

142.9

308.2

1.51

105

(3010375) cycloSPORINE [Mass/volume] in Blood

185

3.70

21.72

38.0

24.1

ug/l

111.7

110.1

0.07

149

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

171

767

2.26

21.68

1.2

u/ml

304.5

278.3

0.56

114

486

(3005322) IgE [Units/volume] in Serum or Plasma

544

3528

1.59

21.52

1.4

1.3

u/ml

189.5

214.8

0.27

507

3264

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

812

5740

1.47

21.46

4.0

3.2

—

(3037756) Immunofixation for Serum or Plasma

223

1118

2.03

21.25

1.4

1.2

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

445

2759

1.65

21.15

2.6

2.2

nmol/l

12.1

14.1

2.99

380

2393

(3007930) Methemoglobin/Hemoglobin.total in Blood

398

2397

1.70

21.13

5.5

4.7

0.9

0.06

373

2248

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

401

2430

1.69

20.80

5.5

4.6

1.6

0.14

379

2279

(3015171) Extractable nuclear Ab [Units/volume] in Serum

405

2472

1.68

20.44

1.3

u/ml

1.5

0.9

0.28

237

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

219

3.36

20.15

1.4

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

219

3.36

20.15

1.4

1.5

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

821

5883

1.45

20.14

1.8

1.7

1.5

0.82

694

5088

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

127

517

2.48

20.07

1.1

—

(3003181) Sodium [Moles/volume] in Urine

212

1066

2.02

20.06

1.3

1.4

mmol/l

58.2

63.6

1.36

167

852

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

175

821

2.16

19.90

1.2

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

217

1105

1.99

19.82

1.7

1.6

—

(3042733) HLA Ab [Presence] in Serum

138

4.01

19.71

4.7

5.1

—

(3026250) Tacrolimus [Mass/volume] in Blood

165

3.72

19.68

38.2

32.4

ug/l

6.9

7.4

0.89

151

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

170

795

2.17

19.50

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

5.22

19.34

1.9

2.3

e6/l

83.8

127.6

0.81

(40768443) Skin Pathology biopsy report

396

2445

1.66

19.13

1.2

—

(3016750) Collection duration of Urine

338

2.80

19.05

2.4

2.2

min

495.9

502.6

0.29

260

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

147

659

2.26

18.72

1.4

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

240

1295

1.88

18.50

1.3

1.2

—

(3051651) Icteric interference index of Serum or Plasma

263

3.03

18.40

3.7

4.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

163

771

2.14

18.19

1.4

1.3

—

(21494815) CD4 cells/100 lymphocytes in Specimen

266

2.99

18.05

1.8

2.2

44.8

45.9

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

289

1672

1.76

17.74

1.6

1.4

iu/ml

9.8

18.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

125

538

2.35

17.53

3.9

3.6

—

(21494434) Karyotype in Bone marrow

102

400

2.57

17.48

1.1

—

(3011985) Renin [Units/volume] in Plasma

165

797

2.10

17.45

1.7

1.3

mu/l

46.2

61.1

0.82

142

709

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

241

3.05

17.27

2.0

2.2

e6/l

612.1

771.5

1.00

110

(3002331) Protein [Mass/volume] in Peritoneal fluid

4.57

17.00

2.0

1.5

g/l

20.6

25.4

0.84

(40768806) Pleura Pathology biopsy report

101

400

2.55

16.98

1.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

584

4047

1.48

16.95

2.4

au/ml

19.2

29.2

0.66

187

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

349

2.66

16.87

1.1

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

101

402

2.53

16.81

1.4

1.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

101

402

2.53

16.81

1.4

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

101

402

2.53

16.81

1.4

1.3

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

372

2337

1.62

16.78

1.1

u/ml

2.8

1.4

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

343

2112

1.66

16.76

2.3

ug/l

377.6

672.1

1.53

327

1979

(3026389) Candida sp identified in Specimen by Organism specific culture

170

844

2.04

16.72

1.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1838

15264

1.27

16.70

4.3

3.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

539

3691

1.50

16.58

1.3

au/ml

42.3

50.4

0.30

155

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

148

701

2.13

16.50

1.5

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

366

2.59

16.37

2.3

2.4

—

(3003434) Protein [Mass/volume] in Pleural fluid

129

580

2.25

16.37

1.5

g/l

31.0

29.4

0.67

109

502

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

295

1762

1.70

16.18

1.5

1.6

iu/ml

0.2

1.9

0.56

381

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

140

655

2.16

16.11

2.1

1.6

32.1

32.8

1.13

140

649

(3004775) Volume in Urine collected for unspecified duration

115

497

2.34

16.02

2.8

2.3

702.1

632.6

1.35

341

(3016650) Hepatitis A virus Ab [Presence] in Serum

157

772

2.06

15.88

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

221

1228

1.82

15.57

1.4

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

256

1487

1.75

15.53

1.1

u/ml

8.2

6.6

0.11

158

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

105

443

2.39

15.45

1.1

1.0

mg/l

290.1

0.00

397

(3024471) HLA-A [Type]

131

3.68

15.36

1.0

—

(3044007) Cell count panel - Peritoneal fluid

109

3.96

15.26

2.8

2.3

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

119

535

2.24

15.13

1.4

1.3

nmol/l

1.5

0.20

110

482

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

6025

57392

1.30

14.97

4.6

4.1

mmol/l

1.3

7.94

5518

52113

(40765096) Chromosome analysis panel by Banding

4.80

14.92

1.2

1.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

268

2.78

14.88

1.9

2.4

u/ml

1215.2

792.7

0.45

263

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1106

8733

1.31

14.58

1.5

1.4

—

(3036603) Volume of Urine

352

2.52

14.55

1.4

1986.2

1976.7

0.02

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

255

2.80

14.52

2.6

2.0

94.4

98.1

0.34

234

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

255

1513

1.71

14.37

2.0

mg/l

12.1

11.1

1.31

240

1389

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

4.39

14.23

1.3

1.2

—

(3024928) Oxygen saturation in Venous blood

214

1212

1.79

14.19

4.9

3.3

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

430

2902

1.51

14.19

3.4

2.5

e6/l

0.2

0.3

0.24

424

2817

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

139

3.47

14.10

3.8

2.8

—

(3039000) Anion gap in Blood

215

1223

1.78

14.05

7.7

6.5

mmol/l

11.4

11.3

0.13

196

1095

(3018572) Chloride [Moles/volume] in Blood

215

1224

1.78

14.02

7.7

6.5

mmol/l

105.0

104.8

0.17

196

1096

(3024932) HLA-DR beta [Type]

130

3.55

14.01

1.0

1.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

184

1001

1.86

13.92

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

105

466

2.27

13.81

1.6

1.5

e6/l

46212.6

61329.5

0.24

270

(3023199) Leukocytes [#/volume] in Pleural fluid

114

526

2.19

13.65

1.6

1.5

e6/l

1596.7

2620.6

1.16

384

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

147

748

1.99

13.58

1.3

pmol/l

281.2

273.6

0.09

127

569

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

7.16

13.54

1.1

1.0

ug/l

2.0

1.4

0.48

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

5.57

13.34

2.5

2.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

337

2.48

13.34

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

388

2.36

13.15

1.3

u/l

275.9

309.5

0.24

362

(4094501)

275

1706

1.64

13.10

1.1

—

(3045788) Cell count panel - Pleural fluid

408

2.32

13.05

1.6

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

177

974

1.84

12.94

1.3

1.4

pmol/l

213.9

71.8

0.91

172

949

(3012501) Base excess in Blood by calculation

208

1202

1.75

12.91

4.5

4.0

mmol/l

2.8

2.6

0.38

153

801

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

180

3.02

12.67

1.4

1.3

umol/l

3.0

3.7

0.82

171

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

257

1582

1.65

12.64

2.7

2.3

ug/min

127.6

112.0

0.18

157

920

(3037121) Protein [Mass/volume] in Urine

293

1865

1.60

12.58

3.1

2.5

g/l

0.3

0.05

158

599

(3036782) Glucose [Moles/volume] in Pleural fluid

384

2.33

12.54

1.3

mmol/l

6.6

6.8

0.24

343

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

146

764

1.93

12.48

1.3

1.2

u/ml

5.9

4.4

0.38

330

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

4.22

12.42

1.6

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

176

980

1.82

12.40

1.4

1.3

u/l

14.2

10.9

1.84

139

785

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

231

1391

1.68

12.37

1.2

—

(3047181) Lactate [Moles/volume] in Blood

281

1779

1.60

12.35

7.1

5.6

mmol/l

1.4

1.3

0.37

249

1566

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

320

2.45

12.29

1.9

1.6

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

251

2.64

12.16

2.3

1.7

nmol/l

1.6

4.9

2.30

200

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

160

871

1.86

12.13

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

310

2.47

12.13

1.1

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

384

2.31

12.10

1.1

1.2

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

311

2.46

12.05

1.1

1.0

—

(3010421) pH of Blood

233

1421

1.66

11.90

4.5

3.9

7.4

0.23

206

1171

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

382

2.29

11.80

1.1

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

433

2.21

11.79

1.1

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

6336

61136

1.30

11.62

5.9

5.2

mmol/l

2.6

2.7

23.81

5877

56127

(3022493) Free Hemoglobin [Mass/volume] in Plasma

223

2.70

11.58

6.3

5.2

mg/l

112.1

64.3

0.70

154

(3021387) Prolactin [Units/volume] in Serum or Plasma

216

1304

1.68

11.49

2.0

1.7

mu/l

319.9

309.2

0.18

202

1178

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

131

681

1.94

11.45

1.4

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

146

787

1.87

11.44

1.3

1.2

u/ml

3.4

4.2

0.18

264

(3025468) Yersinia sp identified in Specimen by Organism specific culture

130

675

1.94

11.41

1.4

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

100

472

2.13

11.39

3.2

2.8

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

6173

59408

1.27

11.26

5.1

4.6

mmol/l

1.4

1.5

23.30

5702

54423

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

4.32

11.20

1.7

1.5

u/l

29.3

52.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

131

687

1.92

11.17

1.4

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

129

674

1.93

11.12

1.4

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

129

677

1.92

10.98

1.4

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

163

923

1.78

10.91

1.4

1.2

u/l

40.0

27.3

0.87

150

788

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

351

2.29

10.90

1.4

1.5

umol/l

12.5

13.3

0.41

328

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

6210

59852

1.27

10.88

5.2

4.7

mmol/l

4.5

4.7

31.34

5784

55170

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

103

502

2.07

10.81

1.8

1.5

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

502

3674

1.39

10.80

1.2

iu/ml

112.6

143.2

1.28

195

1409

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

132

705

1.89

10.67

1.4

1.3

—

(3023419) Bacteria identified in Sputum by Culture

137

744

1.86

10.53

3.3

2.4

—

(3012441) Differential panel - Pleural fluid

434

2.13

10.53

1.6

1.5

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

171

994

1.74

10.48

1.7

1.9

u/l

6392.8

3451.8

0.56

389

(3020717) Zinc [Moles/volume] in Serum or Plasma

247

2.52

10.46

1.6

1.3

umol/l

18.4

20.3

0.22

233

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

494

3629

1.39

10.40

3.8

3.4

kpa

5.1

5.2

1.25

456

3341

(3009343) pH of Capillary blood

488

3579

1.39

10.37

3.8

3.4

7.4

0.93

454

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

281

2.40

10.14

1.1

u/l

22.2

24.1

0.19

205

(3004809) Band form neutrophils/100 leukocytes in Blood

127

682

1.88

10.12

4.4

2.7

1.2

0.07

521

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

471

3449

1.39

10.11

3.8

3.4

mmol/l

1.6

2.0

1.07

349

2569

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

232

1475

1.59

10.08

1.4

—

(3017732) Neutrophils [#/volume] in Blood

540

4049

1.36

10.01

2.8

e9/l

4.1

0.24

393

2997

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

283

2.38

9.99

1.1

u/l

89.2

84.3

0.25

213

(3051611) Lipemic interference index of Serum or Plasma

110

567

1.95

9.92

3.6

3.5

—

(3016038) Potassium [Moles/volume] in Urine

412

2.13

9.88

1.2

1.1

mmol/l

31.3

34.3

0.59

336

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

3.72

9.84

1.2

1.0

ug/l

99.6

77.4

1.06

(1616796) Gas panel - Central venous blood

194

1188

1.65

9.83

4.2

3.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

323

2.27

9.80

2.0

1.5

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

107

549

1.96

9.78

1.2

1.1

92.4

94.8

0.40

100

514

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

180

1083

1.68

9.76

4.1

2.8

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

108

560

1.94

9.59

1.1

—

(3025315) Body weight

4.78

9.52

4.6

3.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

500

1.99

9.48

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

111

587

1.90

9.31

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

319

2.24

9.22

1.5

1.7

mmol/24h

5.6

6.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

141

2.92

9.20

1.2

pmol/l

316.1

279.4

0.28

(4306422)

134

755

1.79

9.20

1.2

—

(3035880) pH of Pleural fluid

227

2.48

9.16

1.2

1.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

248

1639

1.53

9.13

1.5

—

(40768446) Kidney Pathology biopsy report

181

2.66

9.09

1.7

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

788

6316

1.28

9.05

1.7

1.6

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

421

2.06

9.00

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

285

2.29

8.95

1.1

1.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

317

2.22

8.93

1.4

1.3

u/l

186.3

316.3

1.42

288

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

129

727

1.79

8.86

1.2

1.1

124.6

116.1

1.65

121

648

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1969

17370

1.18

8.85

5.5

3.9

ug/l

2.7

2.3

0.74

1767

15576

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

282

2.28

8.72

1.3

u/l

10.7

11.1

0.11

247

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

134

769

1.76

8.67

1.1

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

341

2.15

8.64

1.5

u/l

5.6

6.0

0.32

294

(3039162) Centromere protein B Ab [Units/volume] in Serum

132

757

1.76

8.56

1.3

u/ml

63.8

48.8

0.28

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

120

3.01

8.55

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1156

9741

1.22

8.48

3.2

2.8

ug/l

0.8

0.7

0.70

854

6683

(3017704) Immunofixation for Urine

301

2.20

8.31

1.5

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

276

2.26

8.27

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

470

1.95

8.23

1.2

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

264

2.28

8.23

1.1

1.2

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

107

3.09

8.23

1.2

1.4

28.7

25.5

0.22

(21494814) CD8 cells/100 lymphocytes in Specimen

123

2.94

8.21

1.9

2.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

3.21

8.19

2.0

2.2

—

(3022313) Gas panel - Capillary blood

357

2589

1.40

8.16

3.8

3.5

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.91

8.13

1.5

1.3

—

(3006270) Folate [Moles/volume] in Blood

102

553

1.86

7.99

1.2

nmol/l

359.1

345.4

0.18

449

(3028626) Oxygen [Partial pressure] in Capillary blood

185

1186

1.57

7.85

3.2

2.8

kpa

8.2

8.0

1.22

172

1096

(3023323) Follitropin [Units/volume] in Serum or Plasma

273

1900

1.45

7.85

1.4

1.3

iu/l

33.0

32.8

0.04

231

1665

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

330

2.10

7.74

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

105

582

1.82

7.68

1.5

1.3

u/l

31.8

31.4

0.04

431

(3042631) Mycobacterium sp identified in Specimen

120

693

1.74

7.65

2.3

3.0

—

(21494755) Public health laboratory ask at order entry panel

301

4160

0.71

7.61

1.3

1.4

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1888

16768

1.17

7.61

1.7

1.6

mmol/l

1.4

1.3

3.34

1626

13905

(3047189) Immunofixation for 24 hour Urine

218

2.35

7.50

1.8

1.2

—

(40757373) Influenza virus identified in Isolate

103

3.02

7.44

1.8

1.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

4.40

7.42

1.3

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

3.90

7.42

2.9

1.3

ng/l

51.9

99.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

114

2.90

7.41

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

336

2.06

7.40

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

220

2.33

7.36

1.2

1.3

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

203

2.37

7.24

3.2

2.5

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

275

1947

1.43

7.24

1.6

1.8

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

111

2.89

7.14

1.2

1.4

3.4

3.0

0.07

100

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

139

2.67

7.13

1.2

1.4

53.7

60.2

0.43

118

(3032352) Blasts [#/volume] in Cerebral spinal fluid

5.66

7.06

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

153

964

1.60

7.03

1.4

1.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

164

2.51

6.98

1.2

1.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

351

2.00

6.96

1.1

1.0

nmol/l

7.6

6.2

0.10

(44813793)

380

1.96

6.88

1.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

267

1903

1.42

6.80

1.9

1.7

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

2.94

6.68

1.2

1.5

mu/l

555.9

439.3

0.50

(3008295) Osmolality of Serum or Plasma

550

1.77

6.64

1.3

1.5

mosm/kgh2o

278.7

277.4

0.22

415

(3006653) Thiamine [Moles/volume] in Blood

277

2.10

6.59

1.6

1.2

nmol/l

137.1

137.9

0.06

277

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

197

1334

1.49

6.57

1.3

1.2

u/ml

8.5

6.6

0.14

106

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

100

2.91

6.56

1.2

1.5

68.1

70.8

0.27

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

3.44

6.55

6.0

4.5

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

183

1224

1.51

6.49

1.2

mmol/l

3.8

0.30

169

1149

(40757494) Bilirubin.total [Moles/volume] in Blood

340

1.98

6.47

2.1

2.0

umol/l

19.1

14.6

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

122

743

1.65

6.46

1.1

u/ml

3.1

3.9

0.34

350

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

432

1.86

6.43

1.6

1.3

u/ml

0.4

0.9

1.08

209

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

157

1020

1.55

6.37

3.2

3.5

58.9

58.0

0.40

157

1020

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1574

13968

1.16

6.24

4.8

3.8

21.9

24.1

7.99

837

6820

(1761482) Bacteria [#/volume] in Urine by Culture

228

1606

1.43

6.23

5.0

4.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

541

1.75

6.15

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

110

2.73

6.10

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

196

1348

1.47

6.08

3.3

3.1

nmol/l

0.8

2.03

154

1052

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

196

1356

1.46

5.91

1.3

1.2

u/ml

10.5

18.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

106

638

1.67

5.91

1.6

—

(3021901) Oxygen saturation in Capillary blood

153

1007

1.53

5.89

3.3

2.7

—

(3020393) Adenovirus Ag [Presence] in Stool

4.01

5.89

1.0

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

237

2.12

5.83

1.3

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

237

2.12

5.83

1.3

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

183

1254

1.47

5.81

1.3

1.2

u/ml

20.5

46.9

2.48

143

(3043410) Blood group antigens tested for on Red Blood Cells

131

2.53

5.76

1.7

1.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

118

736

1.61

5.74

2.8

2.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

213

1508

1.43

5.69

1.7

1.6

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

178

1221

1.47

5.63

1.3

e6/l

35.1

28.1

0.12

145

968

(3015235) Bicarbonate [Moles/volume] in Capillary blood

206

1453

1.43

5.63

3.6

3.0

mmol/l

24.4

25.0

1.39

184

1284

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

178

1222

1.47

5.61

1.3

1.4

e6/l

1307.4

1378.7

0.02

152

1023

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

3.82

5.53

1.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

469

1.76

5.52

1.1

—

(4211845)

312

1.93

5.46

4.1

3.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

111

691

1.62

5.46

1.1

u/ml

3.7

2.8

0.16

289

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

434

1.78

5.45

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

438

1.77

5.30

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

438

1.77

5.30

1.2

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

240

1759

1.38

5.28

1.4

1.3

u/ml

16.3

50.0

1.64

108

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

439

1.76

5.26

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

4.62

5.25

1.0

—

(3000330) Specific gravity of Urine by Test strip

408

3232

1.28

5.21

4.4

3.4

—

(37021550) Renin [Units/volume] in Plasma --upright

126

2.47

5.19

1.1

1.3

mu/l

36.9

60.0

0.77

(40759836) Histone Ab [Presence] in Serum by Immunoblot

434

1.76

5.17

1.2

—

(3045424) Erythrocytes [Presence] in Urine

150

1014

1.49

5.14

1.9

1.5

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

435

1.76

5.14

1.2

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

313

1.89

5.09

2.2

2.1

ug/min

166.8

200.9

0.13

(4268621)

527

1.68

5.06

2.2

2.3

—

(3045414) Leukocytes [Presence] in Urine

357

2795

1.29

5.01

2.0

1.9

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

111

707

1.58

5.00

1.0

—

(3006462) Nitrate [Presence] in Urine

287

1.92

4.99

4.1

3.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

225

1648

1.38

4.99

1.9

1.5

e6/l

9878.1

12671.4

0.97

165

1193

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

220

1607

1.38

4.96

1.4

1.3

u/ml

10.8

4.7

0.30

173

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

470

1.71

4.95

1.5

1.4

nmol/l

0.3

0.4

0.58

366

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

196

1405

1.41

4.94

1.3

mg/l

465.3

530.2

1.51

188

1323

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

296

1.90

4.90

1.2

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

227

2.03

4.89

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

162

2.23

4.83

1.9

1.3

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

156

2.25

4.80

1.4

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

158

1095

1.45

4.80

1.2

1.4

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

150

2.27

4.78

1.3

1.1

109.1

110.1

0.04

134

(40761539) Cells [Type] in Urine sediment by Light microscopy

119

2.44

4.78

1.1

1.2

—

(3033942) Copper [Moles/time] in 24 hour Urine

5.01

4.77

1.0

1.1

umol/24h

0.4

0.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

111

721

1.55

4.62

1.1

u/ml

0.6

0.8

0.37

282

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

220

1627

1.36

4.62

1.4

1.3

u/ml

3.2

4.9

0.81

269

(3004451) EKG impression Narrative

281

1.89

4.62

1.4

1.3

—

(3016135) IgD [Mass/volume] in Serum

14.01

4.57

1.3

1.0

mg/l

53.1

298.1

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.68

4.57

1.3

nmol/l

3.6

447951.5

0.91

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

318

1.83

4.56

1.4

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

147

2.25

4.55

1.5

2.1

u/ml

4487.8

82187.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.77

4.53

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

130

879

1.49

4.50

1.7

1.9

pmol/l

180.9

197.5

0.83

120

820

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.72

4.50

1.1

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

126

847

1.50

4.49

1.2

1.1

u/ml

2.1

1.2

0.39

317

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

148

2.24

4.48

1.1

84.0

92.2

0.44

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

2.53

4.45

1.2

1.3

ug/l

226.2

69.8

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

187

1358

1.39

4.41

2.6

2.2

g/l

123.4

130.7

2.99

134

992

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

292

2267

1.30

4.41

4.0

3.7

mmol/l

24.8

25.0

0.69

264

2073

(3035320) C reactive protein [Mass/volume] in Body fluid

397

1.72

4.35

2.2

2.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

194

1423

1.37

4.32

1.8

iu/l

80.9

4.6

0.50

501

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

4.55

4.30

1.8

1.4

mg/l

0.7

5.5

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

4.55

4.30

1.8

1.4

mg/l

1.8

5.2

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

4.55

4.30

1.8

1.4

mg/l

0.9

2.0

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.55

4.30

1.8

1.4

mg/l

1.3

2.5

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

4.55

4.30

1.8

1.4

mg/l

0.4

1.4

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

4.55

4.30

1.8

1.4

mg/l

1.1

3.5

—

(3012565) Volume of 24 hour Urine

274

1.87

4.29

2.4

2.0

1898.7

1931.4

0.08

241

(3017569) Oxygen content in Arterial blood

311

1.81

4.25

2.5

2.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.88

4.25

1.0

—

(40767503) Oxygen content in Capillary blood by calculation

164

1173

1.41

4.24

3.1

2.5

16.0

16.4

0.56

617

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

3.27

4.18

1.2

1.4

73.1

70.6

—

(3009871) Measles virus Ab [Titer] in Serum

160

2.13

4.14

1.5

1.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

167

2.10

4.11

1.4

1.3

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.35

4.08

1.8

1.4

mg/l

1.0

2.3

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

324

1.77

4.03

1.9

1.7

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

310

1.78

4.00

1.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

210

1.96

4.00

3.1

2.8

umol/l

29.8

28.5

0.33

155

(4034850)

160

2189

0.72

3.95

14.7

9.8

—

(3001186) Copper [Moles/volume] in Serum or Plasma

131

2.22

3.91

1.2

umol/l

16.8

16.5

0.12

124

(3001964) Herpes simplex virus Ag [Presence] in Specimen

144

2.16

3.91

1.9

1.4

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

164

2.08

3.90

1.4

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

164

2.08

3.90

1.4

1.3

—

(3021788) Differential panel - Synovial fluid

165

1201

1.38

3.89

1.6

1.5

—

(3008536) Aspergillus sp Ab [Presence] in Serum

2.64

3.89

3.0

1.6

—

(3022689) Creatine [Moles/volume] in Urine

206

1.95

3.85

1.7

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

346

4255

0.80

3.83

1.9

1.8

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

352

1.71

3.82

1.1

iu/ml

5.0

11.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

506

1.59

3.81

1.2

1.6

—

(3044927) Protein electrophoresis panel - Urine

101

675

1.50

3.77

1.2

—

(3052592) Norovirus Ag [Presence] in Stool

114

2.29

3.77

1.5

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

484

1.60

3.77

4.5

3.0

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

3.53

3.76

2.9

2.4

73.6

68.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.73

3.74

1.2

1.1

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

154

2.08

3.71

1.1

89.6

89.7

0.00

(3023410) Appearance of Cerebral spinal fluid

494

1.59

3.70

1.4

—

(1761868) Lipid panel - Serum or Plasma

1827

19750

0.90

3.70

3.2

3.0

—

(3044941) Cell count panel - Synovial fluid

144

1035

1.40

3.68

1.7

1.3

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

3.67

3.63

1.0

1.1

u/ml

21.8

29.9

—

(3028433) Virus identified in Specimen by Culture

170

2.00

3.58

1.1

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

117

2.23

3.56

2.2

2.3

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

6.16

3.50

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

459

3858

1.20

3.49

1.3

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

3.55

3.48

1.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

272

1.77

3.48

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

231

1801

1.29

3.46

1.5

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

326

1.69

3.41

1.6

1.4

nmol/l

1.2

1.3

0.22

256

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

497

1.56

3.40

2.1

1.7

—

(3048879) Bone marrow aspiration report

127

2.13

3.34

1.3

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.44

3.33

1.9

1.3

umol/24h

380.0

319.7

0.19

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.92

3.29

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

102

2.26

3.28

1.3

1.2

75.9

75.3

—

(3019225) pH of Specimen

695

6082

1.16

3.27

5.0

3.6

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

8.58

3.26

1.2

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

142

2.05

3.25

1.4

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

293

1.71

3.25

1.2

1.3

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

2.38

3.22

1.2

1.1

pmol/l

1.9

4.4

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

3.58

3.19

6.4

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

3.58

3.19

1.0

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

3.58

3.19

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

150

2.00

3.19

1.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

111

784

1.42

3.18

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

467

1.55

3.14

4.9

2.6

58.9

59.9

0.13

309

(4212803)

2.96

3.13

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

152

1.98

3.08

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

283

1.70

3.07

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

2.89

3.02

1.4

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

196

1.84

3.01

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

2.70

2.88

1.1

—

(40762887) Creatinine [Moles/volume] in Blood

6.67

2.86

1.3

1.2

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

185

1.84

2.86

1.2

1.6

ug/l

10.9

8.9

1.32

185

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.93

2.85

1.2

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.93

2.85

1.3

1.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

117

853

1.38

2.84

1.1

iu/ml

42.6

13078.1

0.56

185

(3034274) Bile acid [Moles/volume] in Serum --fasting

392

1.56

2.81

2.0

1.8

umol/l

12.5

6.9

1.03

274

(3010726) Horse dander IgE Ab [Units/volume] in Serum

662

1.43

2.79

1.1

u/ml

1.1

2.5

1.27

150

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.55

2.78

1.1

1.2

u/l

3276.4

581.6

—

(3011648) Oxygen content in Venous blood

442

1.52

2.76

1.7

2.1

11.4

11.1

0.28

442

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

262

1.68

2.75

1.5

1.2

ug/l

4.1

2.8

1.09

219

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

8.34

2.75

1.0

2.7

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

159

1.89

2.74

1.4

1.3

nmol/l

103.5

148.8

1.39

108

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

388

1.55

2.70

1.3

1.4

—

(4027681)

271

1.66

2.70

1.1

1.2

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

1330

0.72

2.68

3.7

3.6

mg/l

32.2

26.0

0.81

854

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

487

1.48

2.65

1.4

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

250

1.68

2.64

1.2

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

140

1.93

2.64

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

161

1247

1.30

2.63

1.2

1.3

miu/ml

211.8

213.7

0.02

568

(3019832) Treponema pallidum Ab [Presence] in Serum

339

2860

1.19

2.56

1.6

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

338

1.57

2.55

1.0

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.36

2.55

1.0

—

(3000012) Reticulocyte production index

315

1.59

2.54

1.3

1.4

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

101

2.08

2.52

1.3

1.2

93.7

76.9

—

(3006576) Bicarbonate [Moles/volume] in Blood

202

1.74

2.47

7.6

6.9

mmol/l

23.2

25.1

1.18

182

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.38

2.46

1.8

1.7

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

248

1.66

2.45

1.2

1.4

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

233

1.68

2.44

1.5

1.2

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

107

791

1.36

2.43

2.4

2.2

mg/l

34.8

22.8

0.90

202

(3020874) Milk IgE Ab [Units/volume] in Serum

241

1.66

2.43

1.1

1.0

u/ml

0.8

0.06

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

241

1.66

2.43

4.4

2.2

umol/l

259.2

135.1

0.48

131

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

3.64

2.36

2.3

2.2

mg/l

1.8

2.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

360

0.50

2.35

1.3

1.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

125

1.92

2.34

1.1

1.0

u/ml

0.7

1.5

0.49

(3023511) Choriogonadotropin [Units/volume] in Urine

543

1.42

2.32

1.3

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

112

1.97

2.29

1.3

1.4

19.7

28.0

0.77

(3029075) Extractable nuclear Ab panel - Serum

148

1.83

2.28

1.0

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

236

2842

0.82

2.25

1.6

1.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

3.89

2.25

1.1

1.7

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

142

1.83

2.22

1.1

1.2

umol/24h

0.9

0.6

1.22

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

5.56

2.21

1.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

102

763

1.34

2.18

1.3

1.2

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

542

1.41

2.18

1.1

u/ml

4.8

4.3

0.10

202

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

416

3626

1.16

2.16

1.9

1.8

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

313

1.54

2.15

1.7

2.0

u/field

2.8

2.6

0.04

215

(3028679) Herpes simplex virus Ab [Presence] in Serum

235

1.62

2.13

1.3

1.2

—

(3034426) Prothrombin time (PT)

189

1.70

2.12

1.3

1.2

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

379

1.48

2.12

1.2

1.1

mg/l

37.7

38.8

0.11

321

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.37

2.12

1.1

1.2

u/ml

2.0

0.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.21

2.10

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

3.20

2.09

3.3

2.9

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

198

1.67

2.08

1.2

g/l

0.3

0.87

159

(3028271) Lactate [Moles/volume] in Capillary blood

115

883

1.31

2.07

2.0

1.8

mmol/l

1.8

1.7

0.40

115

862

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.26

2.07

2.1

1.6

umol/l

48.3

45.2

0.18

(40765089) Chromosome analysis panel - Blood by G-banded

2.26

2.07

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

3.50

2.05

1.0

1.1

nmol/l

272.1

255.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

232

1.60

1.98

1.1

1.0

u/ml

0.6

0.05

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

148

1.76

1.98

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

3.34

1.96

1.3

—

(1002224) Polysomnography panel

247

2083

1.19

1.95

1.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

4.55

1.94

1.6

1.4

mmol/24h

1.8

2.7

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

4.55

1.94

16.4

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.19

1.94

1.1

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

218

1.61

1.93

1.4

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

218

1.61

1.93

1.4

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

218

1.61

1.93

1.4

1.3

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.24

1.90

1.3

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

219

1.60

1.90

1.4

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

369

3226

1.15

1.88

1.7

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

1.88

0.0

1.1

—

(40761536) Microorganisms panel - Urine sediment

525

4698

1.13

1.87

5.0

4.0

—

(3016018) Differential panel - Cerebral spinal fluid

559

1.36

1.86

1.2

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

620

1.34

1.84

1.5

28.4

30.4

0.19

381

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

509

1.38

1.84

2.1

2.2

u/field

3.8

1.9

0.89

197

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

3.53

1.83

1.2

1.0

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

197

0.46

1.83

1.7

2.5

nmol/l

130.1

146.7

—

170

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

145

1.73

1.80

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

2.27

1.80

1.2

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

3.05

1.80

1.0

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

131

1.76

1.77

1.3

1.6

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

177

1.64

1.75

1.6

ug/l

0.4

0.11

107

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.22

1.73

1.1

—

(3036525) Urea [Moles/time] in 24 hour Urine

2.67

1.72

3.3

2.8

—

(3045716) Anion gap in Serum or Plasma

306

1.47

1.72

1.6

2.1

mmol/l

7.8

9.2

2.26

235

(3014133) Dog dander IgE Ab [Units/volume] in Serum

585

1.34

1.71

1.1

u/ml

4.1

3.5

0.12

216

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

398

1.41

1.70

1.2

—

(3024263) Appearance of Synovial fluid

348

1.44

1.70

2.0

1.5

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.91

1.69

1.2

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

458

1.38

1.69

1.3

mmol/l

10.2

11.9

1.13

114

(3022475) Manganese [Moles/volume] in Blood

3.16

1.66

1.0

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

3.16

1.66

40.5

7.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.58

1.65

1.4

1.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

478

1.36

1.63

1.1

1.0

u/ml

0.2

0.6

0.70

107

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.25

1.63

1.0

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

573

1.33

1.63

1.1

—

2.7

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.84

1.61

1.4

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.87

1.60

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

707

1.29

1.58

1.9

1.7

90.2

89.7

0.45

697

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

3.00

1.58

5.0

4.9

umol/l

411.5

358.9

—

(3024869) Neuronal Ab [Presence] in Serum

108

1.76

1.50

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.07

1.49

1.2

1.0

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.07

1.49

1.2

1.0

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.07

1.49

1.2

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.04

1.43

1.2

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.97

1.43

1.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

268

2346

1.15

1.41

2.1

1.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

246

2144

1.15

1.38

2.0

1.7

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

142

1.62

1.38

1.1

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

127

1.66

1.36

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.94

1.36

6.0

5.2

—

(3025130) Human papilloma virus identified in Specimen

653

1.27

1.35

1.5

1.7

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

2.13

1.33

1.2

1.1

u/l

16.6

16.5

—

(3032057) Clostridioides difficile [Presence] in Stool

136

1.62

1.32

2.4

1.7

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

471

1.32

1.31

1.1

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

152

1.58

1.31

16.0

7.7

—

(3037556) Urate [Mass/volume] in Serum or Plasma

209

1.49

1.29

1.4

1.2

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

1.76

1.28

1.1

1.2

mmol/l

1.7

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

2.40

1.24

1.2

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.31

1.18

1.2

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.11

1.18

1.1

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.88

1.17

1.1

1.2

umol/24h

2.0

1.7

0.64

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

419

1.32

1.17

1.1

1.4

mmol/l

2.2

2.1

0.16

396

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

307

1.37

1.17

1.3

1.2

ratio

1.0

1.1

1.16

105

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

265

1.40

1.16

1.2

1.1

u/l

1.1

1.0

0.30

118

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

134

1.57

1.14

2.2

2.5

mmol/l

7.5

8.0

0.26

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

750

8005

0.93

1.13

4.8

32.8

33.0

0.16

494

5341

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

275

1.38

1.13

1.2

1.7

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.75

1.12

1.2

1.0

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

127

1.58

1.11

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

345

1.34

1.10

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.26

1.10

1.0

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

212

1866

1.14

1.09

1.4

1.3

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.38

1.09

1.0

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

2.38

1.09

1.0

u/ml

0.1

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

160

1.50

1.09

1.2

1.1

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

2.19

1.08

1.0

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

2.19

1.08

2.4

3.0

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

113

1.59

1.05

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

488

0.74

1.05

1.5

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

306

1.34

1.03

1.2

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

272

1.36

1.02

3.4

4.2

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

114

1.58

1.02

1.4

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.92

1.02

1.1

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.88

1.00

1.4

1.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.71

0.98

1.1

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

302

1.33

0.95

2.5

1.8

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

174

1.44

0.94

1.4

1.3

44.3

38.1

0.34

111

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

133

1.51

0.94

2.3

1.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

200

1.40

0.93

1.1

1.0

u/ml

0.2

0.3

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.72

0.92

2.2

1.6

—

(3050794) Legionella sp Ab [Presence] in Serum

1.73

0.92

1.2

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

662

1.21

0.91

1.4

1.3

e6/l

151588.4

178992.5

0.10

447

(3003577) Lead [Moles/volume] in Blood

2.14

0.91

1.0

1.2

—

0.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.86

0.87

1.8

2.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

102

871

1.17

0.84

1.3

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.76

0.83

1.5

1.9

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.76

0.83

3.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.61

0.81

1.1

1.0

—

(3014271) Vancomycin [Susceptibility]

330

1.27

0.78

3.9

3.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

316

0.73

0.78

1.3

1.4

pmol/l

151.9

158.4

—

(3000034) Microalbumin [Mass/volume] in Urine

629

1.19

0.78

4.3

3.0

mg/l

119.8

28.3

1.48

451

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

225

1.33

0.77

1.2

1.1

103.3

94.3

0.94

169

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

851

1.17

0.77

1.6

1.5

58.9

58.5

0.04

531

(3039443) Prostate specific Ag panel - Serum or Plasma

846

0.84

0.77

1.7

1.6

—

(3015183) Erythrocyte sedimentation rate

226

1.33

0.76

1.1

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.84

0.73

1.4

2.1

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.64

0.73

1.9

2.2

—

(3051593) INR in Capillary blood by Coagulation assay

325

1.26

0.73

19.9

9.9

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

433

1.23

0.73

1.4

1.5

promille

0.9

1.3

0.86

330

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

202

1.34

0.72

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.61

0.72

1.0

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

237

1.31

0.72

1.2

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

282

1.28

0.70

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.92

0.70

1.0

—

(3008898) HLA-B27 [Presence]

195

1768

1.11

0.69

1.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

1.85

0.68

1.2

1.0

—

0.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.56

0.68

1.2

1.1

—

(3011288) Drugs identified in Urine by Screen method

741

1.16

0.68

1.8

2.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

107

939

1.14

0.66

1.8

1.6

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

312

1.25

0.66

1.6

1.5

9.3

4.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

188

1.33

0.66

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

188

1.33

0.66

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

188

1.33

0.66

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

188

1.33

0.66

1.0

1.1

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

111

1.44

0.65

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.54

0.65

1.3

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.54

0.65

1.3

1.2

—

(3004616) Nuclear Ab [Presence] in Serum

811

1.15

0.64

1.5

1.3

—

(3019977) pH of Arterial blood

323

1.24

0.63

3.2

2.5

7.4

0.29

121

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

104

1.44

0.62

1.7

2.9

—

(3002619) Bacteria identified in Specimen by Culture

104

1.44

0.62

1.3

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.67

0.61

1.2

1.0

—

0.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

1.67

0.61

13.4

11.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.57

0.60

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

1.54

0.59

1.0

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

0.00

0.59

0.0

1.0

—

0.0

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.59

0.0

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

192

1.30

0.59

1.0

1.1

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

132

1.36

0.57

19.4

7.5

—

(40758292) HTLV I+II Ab panel - Serum

1.67

0.56

1.0

1.3

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

116

1.38

0.54

1.4

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.50

0.54

1.8

2.1

—

(3028707) Methadone [Presence] in Urine by Screen method

506

1.17

0.53

1.4

2.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

237

0.76

0.51

1.2

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

126

1.35

0.51

1.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

225

1.25

0.49

1.1

ng/l

74.3

450.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

280

1.22

0.48

1.4

1.2

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.49

0.47

1.0

1.1

u/l

13.1

14.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1012

0.90

0.45

2.0

1.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

439

0.84

0.45

1.5

1.4

—

(4015189)

192

1.25

0.44

4.3

2.4

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

175

0.74

0.44

1.2

1.3

—

1182955.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

1.37

0.43

1.2

44.0

50.0

—

(3035933) Granulocytes/100 leukocytes in Blood

104

1.35

0.43

1.3

1.7

—

(3030313) Adrenal Ab [Titer] in Serum

1.61

0.43

1.0

1.1

—

(3005033) Fetal Nuchal fold Thickness US

436

0.85

0.42

1.5

1.4

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.56

0.42

1.4

1.7

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

1.40

0.42

1.0

u/ml

0.0

1.9

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.52

0.41

1.0

1.2

—

(37019676) Renin [Units/volume] in Plasma --supine

0.00

0.41

0.0

1.1

—

29.9

—

(3013293) Extractable nuclear Ab [Presence] in Serum

105

1.33

0.41

1.4

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

432

0.86

0.39

2.0

1.7

—

(3027944) Amphetamines [Presence] in Urine

120

1104

1.09

0.39

1.3

1.7

—

(3016879) Cocaine [Presence] in Urine

113

1037

1.09

0.39

1.3

1.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

224

1.21

0.38

1.1

1.2

g/l

35.7

38.8

0.56

118

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

525

0.88

0.37

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

524

0.88

0.36

1.5

1.4

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

1.43

0.35

1.2

1.4

—

(4024509)

639

0.89

0.35

1.7

1.6

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

135

1.26

0.35

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

522

0.88

0.35

1.5

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

522

0.88

0.35

1.5

1.4

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

118

1.27

0.33

1.8

1.7

—

77.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

229

1.18

0.32

1.0

1.1

miu/ml

1974.0

1605.9

0.96

229

(3009466) Valproate [Moles/volume] in Serum or Plasma

829

1.09

0.31

5.8

4.8

umol/l

350.6

360.9

0.27

708

(3051101) Glucose [Moles/volume] in Cord blood

131

0.76

0.30

6.1

6.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

639

1.10

0.29

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.23

0.29

1.1

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

1.23

0.29

1.0

—

3.4

—

(3026470) Cobalt [Mass/volume] in Blood

482

0.89

0.28

1.9

2.0

ug/l

2.8

3.8

0.53

429

(3043238) Trisomy 21 risk [Likelihood] in Fetus

450

0.89

0.28

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

641

1.09

0.28

1.1

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.32

0.28

1.6

1.8

—

(3027008) Opiates [Presence] in Urine

120

1125

1.07

0.28

1.3

1.7

—

(3014891) Appearance of Pleural fluid

1.23

0.27

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

139

0.79

0.26

1.5

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

159

1.20

0.26

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

119

1118

1.07

0.26

1.3

1.7

—

(3020491) Glucose [Moles/volume] in Blood

433

1.11

0.26

1.9

2.1

mmol/l

7.7

6.7

1.65

291

(3020650) Glucose [Presence] in Urine

141

1.21

0.26

1.2

1.5

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

291

1.13

0.26

2.6

2.3

—

(3028300) Cannabinoids [Presence] in Urine

120

1130

1.06

0.25

1.3

1.7

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

541

1.09

0.24

1.6

u/ml

35.7

23.6

0.82

125

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

204

1953

1.05

0.24

1.8

1.7

mg/l

5.9

3.8

0.92

158

1382

(3001019) Free T4 and TSH panel - Serum or Plasma

236

2455

0.96

0.24

1.6

1.7

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

227

1.15

0.23

1.8

2.1

umol/l

61.0

56.9

0.18

189

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.32

0.23

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.32

0.23

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.28

0.23

1.6

1.5

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.28

0.23

1.0

1.1

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

1.28

0.23

1.2

18.4

14.9

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3034614) HLA Ag [Interpretation]

0.00

0.21

0.0

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.21

0.0

4.1

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

1487.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.0

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

646

0.93

0.20

1.6

1.4

—

(3000285) Sodium [Moles/volume] in Blood

108

1.20

0.20

1.1

—

(3025577) Chromium [Mass/volume] in Blood

469

0.92

0.19

2.1

2.0

ug/l

2.4

2.5

0.10

398

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

184

1.14

0.19

2.6

1.6

—

(44806420)

194

1.13

0.18

2.0

2.4

—

(3014051) Protein [Presence] in Urine by Test strip

139

1448

0.96

0.17

2.2

2.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.22

0.17

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.75

0.17

1.8

2.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.72

0.16

1.6

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.18

0.16

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.18

0.16

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.14

0.16

1.1

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

119

0.84

0.15

1.0

1.1

—

(4146454)

743

1.05

0.14

3.1

2.7

—

(4133840)

138

0.87

0.13

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

220

0.91

0.12

1.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

290

0.93

0.10

1.1

u/ml

4.0

5.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

184

1.09

0.09

2.1

1.8

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.07

0.07

2.0

2.9

u/field

0.7

0.6

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.88

0.06

1.6

1.8

umol/l

14.0

17.6

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

187

1.07

0.06

1.5

mmol/l

8.3

8.5

0.05

110

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

568

0.97

0.06

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

166

1686

0.98

0.06

1.5

1.8

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

109

0.92

0.04

9.2

7.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

260

0.96

0.03

19.4

11.8

nmol/l

758.2

833.7

0.43

245

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

179

0.95

0.03

2.6

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

179

0.95

0.03

2.6

2.5

—

(3022621) pH of Urine by Test strip

414

4158

1.00

0.02

3.7

3.0

—

(4198724)

147

0.95

0.01

1.3

1.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

508

0.98

0.01

1.0

ng/l

43.8

46.4

0.15

331

(3040151) Glucose [Moles/volume] in Capillary blood

673

1.01

0.01

5.1

17.8

mmol/l

7.2

7.5

0.25

544

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

757

0.99

0.01

1.3

1.2

mmol/l

7.2

7.6

0.44

543

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

124

1.05

0.00

1.5

1.4

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

176

1.02

0.00

1.1

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

643

1.00

0.00

4.5

3.0

13.7

13.3

1.65

634

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

505

0.99

0.00

1.0

ng/l

812.8

709.1

0.96

322

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

128

1.02

0.00

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

502

1.00

0.00

1.0

ng/l

342.7

339.0

0.03

335

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.85

0.00

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.93

0.00

19.7

9.8

—

(4038314)

0.00

0.0

1.3

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

3.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

0.00

0.0

2.3

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

122.6

—

(3014171) Thiocyanate [Moles/volume] in Serum or Plasma

0.00

0.0

1.3

—

152.3

—

(44806071)

0.88

0.00

1.3

1.1

—

(3019174) dRVVT (LA screen)

0.98

0.00

1.0

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.94

0.00

1.2

1.1

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

0.0

1.0

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

0.00

0.0

1.6

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_OTHERDIGESTIVE_EXALLC – Benign neoplasm of other and ill-defined parts of digestive system

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Benign neoplasm of other and ill-defined parts of digestive system

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints